resourceId,softwareName,softwareType,softwareVersion,programmingLanguage,sourceRepository,documentation,licenseType,containerized,maintainer,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
,Fiber Photometry Trace Processing,Analysis Software,,MATLAB,https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,,,,,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Fiber Photometry Trace Processing Gradinaru Lab FP_Session_Processing_2.m https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,0.9,Accept,Experimental Usage
,Novoalign tool v3.02.06,Analysis Software,v3.02.06,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Sequence reads were mapped to the human reference genome (GRCh37/hg19) using Novoalign tool v3.02.06,0.95,Accept,Experimental Usage
,PICARD tools v2.4.1,Analysis Software,v2.4.1,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,followed by marking and removing PCR duplicates by PICARD tools v2.4.1,0.95,Accept,Experimental Usage
,Genome Analysis Toolkit (GATK) v3.6-0,Analysis Software,v3.6-0,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Local realignment around insertions/deletions was achieved by Genome Analysis Toolkit (GATK) v3.6-0,0.95,Accept,Experimental Usage
,Mutect v1.1.4,Analysis Software,v1.1.4,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Somatic single-nucleotide variants were identified using Mutect v1.1.4,0.95,Accept,Experimental Usage
,SciClone,Analysis Software,,,,,,,,PMID:32642734 | PMID:32369930,10.1093/noajnl/vdz026 | 10.3390/genes11050499,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Clonality was addressed using SciClone | SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage
,LMSz,Analysis Software,,,,,,,,PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...we implemented a recently described method called 'LMSz' to construct NF1-specific head circumference growth charts...,0.9,Accept,Experimental Usage
,gamlssTools,Package/Library,,R,https://github.com/BGDlab/gamlssTools,,,,,PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...GAMLSS model visualization was performed using customized R functions (https://github.com/BGDlab/gamlssTools)...,0.9,Accept,Experimental Usage
,AXION Biosystems integrated studio (AxIS) version 2.5.1,Analysis Software,2.5.1,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,All neurons were recorded for 3 min at a 4.5 standard deviation threshold level and 5000 Hz as a digital filter using AXION Biosystems integrated studio (AxIS) version 2.5.1 software,0.95,Accept,Experimental Usage
,Offline sorter x64 version 4,Analysis Software,4,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Representative traces of action potentials were extracted using the AXION Biosystems neural metric tool and Offline sorter x64 version 4 software,0.9,Accept,Experimental Usage
,ImageJ 1.53a,Analysis Software,1.53a,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"Images were acquired using Image Studio Lite Version 5.2 software, and LAS AF Lite 3.2.0 software and analyzed using ImageJ 1.53a software",0.9,Accept,Experimental Usage
,"Partek Flow software, version 10.0",Analysis Software,10.0,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"The analysis for this paper was generated using Partek Flow software, version 10.0 using publicly available datasets",0.95,Accept,Experimental Usage
,STAR version 2.7.8a,Analysis Software,2.7.8a,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR version 2.7.8a,0.95,Accept,Experimental Usage
,Splice Site Prediction by Neural Network (SSPNN),Web Application,,,,,,,,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,"The sequence environment of all donor- and acceptor sites was analysed using Splice Site Prediction by Neural Network (SSPNN, URL address:",0.9,Accept,Experimental Usage
,mfold computer program version 3.0,Analysis Software,3.0,,,,,,,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The mfold computer program version 3.0 was used to predict the RNA secondary structure and to calculate the folding free energy,0.95,Accept,Experimental Usage
,Prism7 (GraphPad),Analysis Software,7,,,,,,,PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"Data statistical analyses were performed by unpaired two-tailed Student's t-test (Prism7, GraphPad)",0.85,Accept,Experimental Usage
,Agilent Seahorse XF-96,Analysis Software,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We measured cellular energetics using Agilent Seahorse XF-96 Glyco Stress Test and Mito Stress Test assays,0.9,Accept,Experimental Usage
,STAR v2.7.8a,Analysis Software,v2.7.8a,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,GENCODE was used to map FASTQ files to GRCh38 (release 33 with STAR v2.7.8a basic two-pass mode),0.9,Accept,Experimental Usage
,iDEP 9.1,Analysis Software,9.1,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,principal component analysis was computed using iDEP 9.1,0.9,Accept,Experimental Usage
,Trim Galore v0.6.0,Analysis Software,v0.6.0,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Trim Galore v0.6.0 was used to trim sequencing adapters from demultiplexed FASTQ files,0.9,Accept,Experimental Usage
,LipidSearch v5.0,Analysis Software,v5.0,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Lipid identifications were assigned using LipidSearch (v5.0, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage
,Compound Discoverer v3.2,Analysis Software,v3.2,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Data was analyzed using Compound Discoverer (v 3.2, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage
,SynergyFinder R package,Package/Library,,R,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Synergy was calculated using the SynergyFinder R package,0.9,Accept,Experimental Usage
,CEAS R Package,Package/Library,,R,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"ATP metrics were calculated following Mookerjee et al., 2017 and using the CEAS R Package",0.9,Accept,Experimental Usage
,FactoMineR R package,Package/Library,,R,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,PCA analysis was performed using the FactoMineR R package,0.9,Accept,Experimental Usage
,FlowJo software,Analysis Software,X10.0.7,,,,,,,PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,data were processed with FlowJo software (version X10.0.7),0.85,Accept,Experimental Usage
,Orbitrap Fusion Lumos mass spectrometer,Analysis Software,,,,,,,,PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"An Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA)",0.9,Accept,Experimental Usage
,SEDFIT 16.1,Analysis Software,16.1,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Time-corrected data were analyzed in SEDFIT 16.1 in terms of a continuous c(s) distribution of sedimenting species,0.9,Accept,Experimental Usage
,SEDPHAT 14.0,Analysis Software,14.0,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Data were analyzed globally in terms of a single noninteracting species in SEDPHAT 14.0 to obtain the molar mass,0.9,Accept,Experimental Usage
,EMAN2 e2boxer,Analysis Software,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Negatively-stained neurofibromin particles were autopicked using EMAN2 e2boxer using a box size of 326 pixels,0.9,Accept,Experimental Usage
,Sphire,Package/Library,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Reference-free 2D classification was carried out using the Iterative Stable Alignment and Clustering (ISAC) procedure implemented in a Sphire package,0.9,Accept,Experimental Usage
,ATSAS,Package/Library,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,The reduced SAXS and SANS data were analyzed using the ATSAS tools PRIMUS and GNOM for Guinier and P(r) analysis,0.9,Accept,Experimental Usage
,STAR 2.4.2a,Analysis Software,2.4.2a,,,,,,,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mapping was performed using STAR 2.4.2a software with mouse genome (mm9),0.9,Accept,Experimental Usage
,GSEA software 4.0.1,Analysis Software,4.0.1,,,,,,,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Gene set enrichment analysis (GSEA) was performed with the entire gene list using GSEA software 4.0.1 desktop (Broad Institute),0.9,Accept,Experimental Usage
,DAVID 6.8,Web Application,6.8,,,,,,,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,KEGG and gene ontology (GO) enrichment analysis was performed using the Signature Database (MSigDB) and DAVID 6.8,0.9,Accept,Experimental Usage
,MaxQuant (v1.5.3.30),Analysis Software,v1.5.3.30,,,,,,,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Five micrograms of each SCX fraction and a non-fractioned sample were used for proteome profiling and analysed by MaxQuant (v1.5.3.30),0.9,Accept,Experimental Usage
,AxioVision 4.6 software,Analysis Software,4.6,,,,,,,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed using a Zeiss Stereo Discovery V12 and the AxioVision 4.6 software (Zeiss),0.85,Accept,Experimental Usage
,BwaMem,Analysis Software,v0.7.12,,,,,,,PMID:33025139 | PMID:32369930 | PMID:28051113 | PMID:36598417,10.1007/s00401-020-02230-x | 10.3390/genes11050499 | 10.1038/srep39348 | 10.1158/2159-8290.CD-22-0786,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.",,WGS data were aligned against hg19 using BwaMem v0.7.12 | Genomic data were aligned against reference sequence hg38 via BWA-MEM with Base Quality Score Recalibration (BQSR) | fastq files were mapped against the GRCh37 human genome assembly...using BWA mem | Amplicon reads were aligned against the human reference genome hg19 with BWA MEM | Raw sequencing reads were mapped to the GRCh38 build of the human reference genome using BWA-MEM (46) version 0.7.17-r1188,0.95,Accept,Experimental Usage
,manta,Analysis Software,,,,,,,,PMID:32369930 | PMID:36598417,10.3390/genes11050499 | 10.1158/2159-8290.CD-22-0786,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Structural variants (SVs) and large indels were detected using manta | we called SVs in all matched normal samples using Manta (version 1.6.0; ref. 55),0.9,Accept,Experimental Usage
,Pindel,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage
,GenVisR,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Waterfall somatic variant plots were created with GenVisR by including somatic variants that occurred in each area,0.9,Accept,Experimental Usage
,COSMIC,Database,,,,,,,,PMID:32369930 | PMID:35332608,10.3390/genes11050499 | 10.1002/humu.24370,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Re-evaluation of missense variant classifications in NF2.,,"These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive | COSMIC ( www.cancer.sanger.ac.uk ) (Tate et al., 2019 ) was used in the investigation of variants that were observed in somatic samples",0.9,Accept,Experimental Usage
,ClinVar,Database,,,,,,,,PMID:32369930 | PMID:40887659,10.3390/genes11050499 | 10.1186/s40246-025-00803-z,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive | ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 available at: https://ftp.ncbi.nlm.nih.gov/pub/clinvar/,0.9,Accept,Experimental Usage
,SIFT,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage
,Polyphen,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage
,ClonEvol,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage
,Partek Flow,Analysis Software,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Pre/post quality control and full expectation-maximization (EM) quantification were run via Partek Flow,0.9,Accept,Experimental Usage
,gplots,Package/Library,,R,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Heatmap visualizations were created using gplots R package,0.9,Accept,Experimental Usage
,PantherDB,Database,,,,,,,,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,PantherDB was utilized to discover GO terms and pathways that may be affected by these genes,0.9,Accept,Experimental Usage
,CompuSyn software Version 1.0,Analysis Software,1.0,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"Drug–drug interactions were analyzed with CompuSyn software Version 1.0 (Informer Technologies, Los Angeles, CA, USA; software is available at https://www.compusyn.software.informer.com",0.95,Accept,Experimental Usage
,IBM SPSS Statistics software version 29.0.1.0,Analysis Software,29.0.1.0,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"In vivo S462TY sciatic nerve tumor xenograft data were analyzed using IBM SPSS Statistics software version 29.0.1.0 (IBM, Armonk, NY, USA).",0.9,Accept,Experimental Usage
,SPIN (Signal Processing in MR Version SVN Revision 1895),Analysis Software,SVN Revision 1895,,http://mrc.wayne.edu,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Internally developed MR software SPIN (Signal Processing in MR (Version SVN Revision 1895); http://mrc.wayne.edu (accessed on 15 December 2023)) was used for tumor volume measurement.,0.95,Accept,Experimental Usage
,VarDict,Analysis Software,,Java,,,,,,PMID:28398289 | PMID:36598417,10.1038/sdata.2017.45 | 10.1158/2159-8290.CD-22-0786,A high-throughput molecular data resource for cutaneous neurofibromas. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Somatic mutations were called from BAM files exported by the Dragen alignment using the Java version of VarDict in paired mode | and VarDict (version 1.8.2; ref. 52) were used to detect germline SNVs and INDELs in the WGS data,0.9,Accept,Experimental Usage
,SvABA,Analysis Software,1.1.3,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LUMPY (version 0.2.13; ref. 56), SvABA (version 1.1.3; ref. 57), and Delly (version 0.8.3; refs. 57, 58)",0.85,Accept,Experimental Usage
,MuSE,Analysis Software,v1.0rc,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Somatic SNVs were detected using Mutect2 (GATK version 4.1.8.0), MuSE (version v1.0rc; ref. 60)",0.85,Accept,Experimental Usage
,MSIprofiler,Analysis Software,,,https://github.com/parklab/MSIprofiler,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Mutations at microsatellite loci were detected using MSIprofiler (https://github.com/parklab/MSIprofiler),0.85,Accept,Experimental Usage
,FACETS,Analysis Software,0.12.1,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage
,ascatNGS,Analysis Software,2.5.1,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage
,ShatterSeek,Analysis Software,0.7,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Chromothripsis events were detected using ShatterSeek (version 0.7) using recommended cutoff values (72),0.85,Accept,Experimental Usage
,TopHat-fusion,Analysis Software,2.1.0,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage
,EricScript,Analysis Software,0.5.5,,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage
,minfi,Package/Library,3.3,R,,,,,,PMID:33025139 | PMID:35945463 | PMID:36598417 | PMID:38216587,10.1007/s00401-020-02230-x | 10.1007/s00401-022-02478-5 | 10.1158/2159-8290.CD-22-0786 | 10.1038/s41467-023-40408-5,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,Raw IDAT data files were processed using the minfi Bioconductor package (version 3.3) | Methylation data were preprocessed using the combineArrays function within the minfi package (v.1.38.0) in R Bioconductor | Raw Methylation EPIC data were uniformly processed using the R package minfi (version 1.34.0; ref. 86) | Data preprocessing and normalization was performed using minfi version 1.30 in R version 3.6.0,0.95,Accept,Experimental Usage
,survival,Package/Library,2.30,R,,,,,,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Survival analysis was performed using the Cox proportional-hazards model as implemented in the R package survival (version 2.30; ref. 93),0.85,Accept,Experimental Usage
,GraphPad Prism version 6.0h,Analysis Software,6.0h,,,,,,,PMID:32781282 | PMID:29847659,10.1016/j.trsl.2020.08.001 | 10.1167/iovs.17-22588,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Analysis was performed using GraphPad Prism version 6.0h (La Jolla, CA, USA)",0.9,Accept,Experimental Usage
,"ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",Analysis Software,1.48,,,,,,,PMID:25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,,"More than 200 cells were counted for each drug concentration using ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",0.9,Accept,Experimental Usage
,ImageJ (v1.53a),Analysis Software,v1.53a,,,,,,,PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,Fiber diameter and angle were measured using ImageJ (v1.53a) with at least 200 fibers per fiber type,0.8,Accept,Experimental Usage
,NIH ImageJ (version 1.53a),Analysis Software,version 1.53a,,,,,,,PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,"The images were analyzed using NIH ImageJ (version 1.53a) software. Aspect ratio, which is the longest length of the cell divided by the shortest length",0.8,Accept,Experimental Usage
,DNA Engine Peltier Thermal cycler (PTC-200),Other,,,,,,,,PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"in a DNA Engine Peltier Thermal cycler (PTC-200; MJ Research, Watertown, MA) at 42°C for 1 minute",0.9,Accept,Experimental Usage
,"ABI Prism 7,000 Sequence Detection System",Analysis Software,,,,,,,,PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"An ABI Prism 7,000 Sequence Detection System was used for all reactions with the following cycling parameters",0.95,Accept,Experimental Usage
,Simpleware ScanIP,Analysis Software,,,,,,,,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models for the ground truth dataset, an image processing software (Simpleware ScanIP, Synopsys) was used.",0.95,Accept,Experimental Usage
,DPP V1.0,Analysis Software,V1.0,,,,,,,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,The helper (DPP V1.0) was trained using proprietary AI- and ML-based algorithms and information.,0.9,Accept,Development
,Simpleware,Analysis Software,,,,,,,,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models an image processing software (Simpleware, Synopsys, Mountain View, CA) was used.",0.95,Accept,Experimental Usage
,Phoenix WinNonlin (Version 8.1),Analysis Software,8.1,,,,,,,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A noncompartmental analysis was performed to estimate area under the concentration-time curve from time 0 to 12 hours (AUC 0-12h) after a single dose of mirdametinib using Phoenix WinNonlin (Version 8.1; Certara, Princeton, NJ).",0.85,Accept,Experimental Usage
,NONMEM (version 7.2),Analysis Software,7.2,,,,,,,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.85,Accept,Experimental Usage
,Perl speaks NONMEM version 3.6.2,Package/Library,3.6.2,Perl,,,,,,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage
,Pirana version 2.7.1,Analysis Software,2.7.1,,,,,,,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage
,"SAS, version 9.4",Analysis Software,9.4,,,,,,,PMID:37378983 | PMID:31462295 | PMID:33507822 | PMID:32572180,10.1001/jamanetworkopen.2023.20599 | 10.1186/s40478-019-0792-5 | 10.1200/JCO.20.02220 | 10.1038/s41436-020-0873-7,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial. | Telomere alterations in neurofibromatosis type 1-associated solid tumors. | NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. | Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,,"We used SAS, version 9.4 (SAS Institute Inc), for analyses | Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA), SAS version 9.4 (Cary, NC) | The pain and QOL data were summarized with descriptive statistics (means, standard deviation [SD]) via SAS version 9.4 (Cary, NC). | Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) and R version 3.5.0",0.85,Accept,Experimental Usage
,SPSS version 28.0,Analysis Software,28.0,,,,,,,PMID:38499890 | PMID:38811427,10.1186/s41687-024-00714-y | 10.1186/s41687-024-00732-w,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands. | Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.",,The statistical analyses were conducted using SPSS version 28.0 | Statistical analyses were performed using SPSS version 28.0,0.85,Accept,Experimental Usage
,www.synapse.org/SynodosNF2,Database,,,www.synapse.org/SynodosNF2,,,,,PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,This work has created an openly accessible resource (www.synapse.org/SynodosNF2) of fully characterized isogenic schwannoma and meningioma cell systems,0.9,Accept,Development
,FastQC (version 0.11.2),Analysis Software,0.11.2,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,All sequencing datasets were evaluated using FastQC (version 0.11.2) to ensure high quality,0.8,Accept,Experimental Usage
,Bowtie (version 1.0.0),Analysis Software,1.0.0,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We first built an index using all sgRNAs in each sample and then used Bowtie (version 1.0.0) to map the sgRNA sequences,0.8,Accept,Experimental Usage
,BWA version 0.7.5,Analysis Software,0.7.5,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We mapped the reads to the reference genomic sequence using BWA version 0.7.5 and SAMtools,0.8,Accept,Experimental Usage
,SAMtools (version 0.1.19),Analysis Software,0.1.19,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We mapped the reads to the reference genomic sequence using BWA version 0.7.5 and SAMtools (version 0.1.19),0.8,Accept,Experimental Usage
,VarScan2 (version 2.3),Analysis Software,2.3,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We then used VarScan2 (version 2.3) to identify insertions and deletions with the 'pileup2indel' mode,0.8,Accept,Experimental Usage
,STAR (version 2.3.0e),Analysis Software,2.3.0e,,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We aligned RNA-seq reads to the mm10 genome using STAR (version 2.3.0e) with default parameters,0.8,Accept,Experimental Usage
,DESeq (version 1.18.0),Package/Library,1.18.0,R,,,,,,PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We then determined differential expression using DESeq (version 1.18.0) and accounted for possible batch effects,0.8,Accept,Experimental Usage
,WGCNA,Package/Library,,R,,,,,,PMID:38115252 | PMID:35741605 | PMID:28166733,10.1097/MD.0000000000036696 | 10.3390/brainsci12060720 | 10.1186/s12864-017-3519-7,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools. | Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"WGCNA, an R package, was used to conduct WGCNA | Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ] | We used the 'collapseRows()' function with the 'maxmean' method from the R package WGCNA",0.95,Accept,Experimental Usage
,ConsensusClusterPlus,Package/Library,,R,,,,,,PMID:35741605 | PMID:33025139 | PMID:38216572,10.3390/brainsci12060720 | 10.1007/s00401-020-02230-x | 10.1038/s41467-024-44755-9,"Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.",,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ], enrichplot [ 29 ], and ConsensusClusterPlus [ 30 ] | Subgroups were identified using ConsensusClusterPlus Bioconductor package | To identify DNA methylation groups, ConsensusClusterPlus (Bioconductor v3.10) was used",0.9,Accept,Experimental Usage
,Mechanism Interrogation PlatE (MIPE 4.0) library,Database,,,,,,,,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,The drug screening data were contributed by Ferrer et al. using the Mechanism Interrogation PlatE (MIPE 4.0) library [ 6 ],0.9,Accept,Experimental Usage
,IDAPredict.2drug function package,Package/Library,,,,,,,,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,IDAPredict.2drug function package was used to predict the drug combination between DrugCluster pairs [ 23 ],0.9,Accept,Experimental Usage
,Barocycler NEP 2320,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Pressure-based cell lysis was performed for 60 cycles of 50 s at 30 °C and 310 MPa using the Barocycler NEP 2320 instrument (Pressure BioSciences, Easton, MA, USA)...",0.9,Accept,Experimental Usage
,Easy-nLC 1200,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...A nanoflow high-performance liquid chromatography system Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany)...",0.9,Accept,Experimental Usage
,Q Exactive HF mass spectrometer,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano-electrospray ionization source...",0.9,Accept,Experimental Usage
,Thermo Xcalibur 4.1,Analysis Software,4.1,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The data were acquired automatically using Thermo Xcalibur 4.1 software (Thermo Fisher Scientific) and processed with the Spectronaut Pulsar software...,0.95,Accept,Experimental Usage
,Spectronaut Pulsar,Analysis Software,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...processed with the Spectronaut Pulsar software (Biognosys, Schlieren, Switzerland). Pulsar is a search engine, integrated into Spectronaut for spectral library generation...",0.95,Accept,Experimental Usage
,BenchMark Ultra system,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The Ki67 immunohistochemistry was performed using the BenchMark Ultra system (Roche)...,0.9,Accept,Experimental Usage
,NanoZoomer S60 digital slide scanner,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...imaged using the NanoZoomer S60 digital slide scanner (Hamamatsu, Hamamatsu City, Japan)...",0.9,Accept,Experimental Usage
,Pannoramic Midi FL slide scanner,Other,,,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...and Pannoramic Midi FL slide scanner (3DHistech Ltd, Budapest, Hungary)...",0.9,Accept,Experimental Usage
,R software version 4.0.0,Analysis Software,4.0.0,R,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All analyses were performed using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage
,lmerTest package version 3.1-2,Package/Library,3.1-2,R,,,,,,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage
,AxioVision 4.1 software,Analysis Software,4.1,,,,,,,PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Images were collected using a DMR HC microscope...and evaluated using AxioVision 4.1 software (Zeiss, Jena, Germany)",0.8,Accept,Experimental Usage
,analySIS 5.0 software,Analysis Software,5.0,,,,,,,PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Stained sections were analyzed using the BX51 microscope...and analySIS 5.0 software (Soft imaging system GmbH, Münster, Germany)",0.8,Accept,Experimental Usage
,Gel-Pro Analyzer 4.0,Analysis Software,4.0,,,,,,,PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"α-tubulin (Sigma, St. Louis, MO) was employed for normalization and densitometric analysis using Gel-Pro Analyzer 4.0 (Media Cybernetics, Bethesda, MD)",0.8,Accept,Experimental Usage
,GraphPad Prism 4.0,Analysis Software,4.0,,,,,,,PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"Statistical analyses were performed using GraphPad Prism 4.0 software (GraphPad, La Jolla, CA)",0.8,Accept,Experimental Usage
,NextGENe software v.2.3.4.1,Analysis Software,v.2.3.4.1,,,,,,,PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"The data were analysed using NextGENe software v.2.3.4.1 (Softgenetics, PA, USA) with the default settings",0.9,Accept,Experimental Usage
,g:Profiler,Web Application,,,,,,,,PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,GO analysis was performed using g:Profiler,0.9,Accept,Experimental Usage
,BioVenn,Web Application,,,,,,,,PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Venn diagrams were generated using BioVenn,0.9,Accept,Experimental Usage
,PathVisio software,Analysis Software,,,,,,,,PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Proximity maps were generated using PathVisio software,0.9,Accept,Experimental Usage
,"Alamut Visual Plus, version 1.5.1",Analysis Software,1.5.1,,,,,,,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"Splice site prediction software (Alamut Visual Plus, version 1.5.1; Sophia Genetics) was used to identify variants likely to affect pre-mRNA splicing",0.9,Accept,Experimental Usage
,R 2.7.0,Analysis Software,2.7.0,R,,,,,,PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,All analyses were performed on R 2.7.0.,0.85,Accept,Experimental Usage
,Axio Vision Rel. 4.8 software,Analysis Software,4.8,,,,,,,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Images were captured and analyzed using Axio Vision Rel. 4.8 software (Carl Zeiss MicroImaging),0.85,Accept,Experimental Usage
,Graphpad Prism 6,Analysis Software,6,,,,,,,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Statistical significance was determined by ANOVA followed by Bonferroni's posthoc test for multiple comparisons and student's t-test for two groups using Graphpad Prism 6 software,0.8,Accept,Experimental Usage
,piXarray 100 DSR System,Analysis Software,1.0.6,,,,,,,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"X-rays were taken using a piXarray 100 DSR System with Biopix Software (Version No: 1.0.6., Bioptics, Inc. Tucson, AZ)",0.8,Accept,Experimental Usage
,XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner,Analysis Software,5.50,,,,,,,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"Whole axial bone was placed in the gantry of a XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner (Stratec Medizintechnik GmbH, Pforzheim, Germany) with Software Version 5.50",0.8,Accept,Experimental Usage
,MtestwR software,Analysis Software,R 1.4.2,,,,,,,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"biomechanical testing was conducted utilizing Testresouse R systems with MtestwR software version: R 1.4.2 (TestResources Inc. Shakopee, MN)",0.8,Accept,Experimental Usage
,FMRIB software library (FSL),Analysis Software,5.0,,,,,,,PMID:27081657 | PMID:28725547,10.1002/acn3.288 | 10.1016/j.nicl.2017.06.032,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I. | Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,"fMRI data analyses were performed using tools from the FMRIB software library ( www.fmrib.ox.ac.uk/fsl ), version 5.0 | FMRI data analyses were performed using the FMRIB software library (www.fmrib.ox.ac.uk/fsl), version 5.0",0.9,Accept,Experimental Usage
,Burrows–Wheeler Aligner,Analysis Software,0.7.8,,,,,,,PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,Burrows–Wheeler Aligner (version 0.7.8) was utilized to map the paired-end clean reads,0.9,Accept,Experimental Usage
,control-FREEC,Analysis Software,9.9,,,,,,,PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,CNV is detected by control-FREEC (version 9.9),0.9,Accept,Experimental Usage
,RStudio,Analysis Software,1.2.5033,R,,,,,,PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,We developed R codes and used RStudio (version 1.2.5033),0.9,Accept,Experimental Usage
,APE,Package/Library,5.2,R,,,,,,PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"R package ""Analyses of Phylogenetics and Evolution"" (APE, version 5.2)",0.9,Accept,Experimental Usage
,MEGAX,Analysis Software,0.1,,,,,,,PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"MEGAX (version 0.1, for MAC) to generate SKY-based phylogenetic trees",0.9,Accept,Experimental Usage
,XenoBase version 3.5,Analysis Software,3.5,,,,,,,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization,0.85,Accept,Experimental Usage
,Affymetrix Expression Console MAS 5.0,Analysis Software,MAS 5.0,,,,,,,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Microarray data was analyzed using Affymetrix expression console MAS 5.0 method,0.8,Accept,Experimental Usage
,StepOne Software v2.3,Analysis Software,v2.3,,,,,,,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,using StepOne Software v2.3 (Applied Biosystems) standard parameters,0.85,Accept,Experimental Usage
,FSL version 5.0.7,Analysis Software,5.0.7,,,,,,,PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,"Postprocessing DTI analysis was performed using a previously described method for automated probabilistic tractography of the optic radiations. Briefly, using FSL version 5.0.7 (FMRIB)",0.85,Accept,Experimental Usage
,"iPlan Net software (Brainlab, Feldkirchen, Germany)",Analysis Software,,,,,,,,PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"postcontrast thin-sliced (≤ 3 mm) T1-weighted magnetic resonance (MR) sequences were uploaded into the iPlan Net software (Brainlab, Feldkirchen, Germany), and volumes were measured manually or in combination with semiautomated segmentation",0.9,Accept,Experimental Usage
,"Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",Analysis Software,10.0,,,,,,,PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"Statistical evaluation was performed using the Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",0.8,Accept,Experimental Usage
,Human Splicing Finder (HSF) Version 2.4.1,Web Application,2.4.1,,,,,,,PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Human Splicing Finder (HSF) Version 2.4.1 ( http://www.umd.be/HSF/ Assessing on 21 December 2020),0.9,Accept,Experimental Usage
,Combined Annotation Dependent Depletion (CADD) v1.6,Web Application,v1.6,,,,,,,PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Combined Annotation Dependent Depletion (CADD) v1.6 ( https://cadd.gs.washington.edu/ Assessing on 21 December 2020),0.9,Accept,Experimental Usage
,CRISPOR,Web Application,,,,,,,,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Target sites within the genes of interest were selected using Massachusetts Institute of Technology's CRISPR design tool (now unavailable, previously: crispr.mit.edu, ), or later, CRISPOR",0.9,Accept,Experimental Usage
,JMP Pro 15.0.0,Analysis Software,15.0.0,,,,,,,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Logistic regressions were performed in JMP (JMP Pro 15.0.0, SAS Institute Inc., Cary, NC)",0.8,Accept,Experimental Usage
,UN-SCAN-IT gel 6.1,Analysis Software,6.1,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,band intensities were quantified using UN-SCAN-IT gel 6.1 software,0.85,Accept,Experimental Usage
,synergyfinder,Web Application,,,https://synergyfinder.fimm.fi/,,,,,PMID:36730269 | PMID:33273014 | PMID:37410426 | PMID:40723243,10.1371/journal.pone.0277305 | 10.1074/jbc.RA120.014960 | 10.1158/1078-0432.CCR-23-0749 | 10.3390/cancers17142359,"Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.",,We used the percent viability compared to untreated cells to calculate a synergy score for each of the analyzed combinations (https://synergyfinder.fimm.fi/) | Synergy scores were generated using the web-based SynergyFinder application (https://synergyfinder.fimm.fi/) | data analyzed using SynergyFinder (RRID: SCR-019318) | Drug synergy was evaluated using the Bliss independence model via the SynergyFinder online platform (https://synergyfinder.org/),0.95,Accept,Experimental Usage
,ImageJ Cell Counter extension,Plugin,,,,,,,,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,The target cell type was counted using the ImageJ Cell Counter extension (NIH),0.9,Accept,Experimental Usage
,R version 3.5.1,Analysis Software,3.5.1,R,,,,,,PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,Statistical analysis was performed using GraphPad Prism 7 and R version 3.5.1.,0.8,Accept,Experimental Usage
,R version 3.5.0,Analysis Software,3.5.0,R,,,,,,PMID:32572180,10.1038/s41436-020-0873-7,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,,"Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) and R version 3.5.0",0.8,Accept,Experimental Usage
,Image Studio Lite software,Analysis Software,,,,,,,,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,Band intensity quantifications were done using Image Studio Lite software (RRID: SCR_013715),0.9,Accept,Experimental Usage
,DINs (Deep Interactive Networks),Analysis Software,,Python,,,,,,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,we propose deep interactive networks (DINs) to address the above limitations. User interactions guide the model to recognize complicated tumors and quickly adapt to heterogeneous tumors.,0.95,Accept,Development
,3DQI software,Analysis Software,,,,,,,,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI),0.9,Accept,Experimental Usage
,MEDx software,Analysis Software,,,,,,,,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI) and MEDx software at NCI,0.9,Accept,Experimental Usage
,InVivo 3.2.0 software,Analysis Software,3.2.0,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software (Media Cybernetics),0.9,Accept,Experimental Usage
,Image-Pro Plus software,Analysis Software,,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Computerized quantitative morphometric analysis was performed using Image-Pro Plus software (Media Cybernetics),0.9,Accept,Experimental Usage
,"Image J1.45s, version 1.44p",Analysis Software,1.44p,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The width and equatorial length of the testes were measured on testicular histological images using Image J1.45s, version 1.44p (NIH, Bethesda, MD)",0.9,Accept,Experimental Usage
,GraphPad 5 Prism software,Analysis Software,5,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"Differences between Nf1+/- and Nf1+/+ groups were analyzed by 2-tailed Student's t tests and were graphed using GraphPad 5 Prism software (San Diego, Calif., USA)",0.85,Accept,Experimental Usage
,REDCap,Web Application,,,,,,,,PMID:37269078,10.1177/17407745231178839,Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.,,"Surveys were created in REDCap, a secure web-based data capture tool",0.9,Accept,Experimental Usage
,"IBM SPSS for Windows, version 28",Analysis Software,version 28,,,,,,,PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,"The data were analyzed using IBM SPSS for Windows, version 28",0.85,Accept,Experimental Usage
,GPower 3.1,Analysis Software,3.1,,,,,,,PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,A post-hoc power analysis was conducted using GPower 3.1 (n = 19),0.85,Accept,Experimental Usage
,netMHCpan-4.0,Analysis Software,4.0,,,,,,,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Binding affinity of mutant and corresponding wild-type peptides to the patient's germline HLA alleles was predicted using netMHCpan-4.0,0.9,Accept,Experimental Usage
,CatWalk XT,Analysis Software,ver. 8,,,,,,,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"We used the CatWalk XT (ver. 8, Noldus Information Technology, Wageningen, The Netherlands) system to study the functional recovery of the nerve",0.9,Accept,Experimental Usage
,Agilent ChemStation software (version C.01.07),Analysis Software,C.01.07,,,,,,,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,An Agilent ChemStation software (version C.01.07) was used for data analysis,0.9,Accept,Experimental Usage
,VivoQuant software version 4.0,Analysis Software,4.0,,,,,,,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"ROIs were manually drawn with VivoQuant software version 4.0 (Invicro, Needham, MA, USA)",0.95,Accept,Experimental Usage
,MaxQuant version 1.3.05,Analysis Software,1.3.05,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Andromeda search engine integrated in MaxQuant version 1.3.05 programme was used to identify the proteins,0.95,Accept,Experimental Usage
,DAVID software,Analysis Software,,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Functional enrichment analysis was performed using Benjamini-Hochberg multiple correction testing integrated in to the database for annotation, visualization and integrated discovery (DAVID) software",0.9,Accept,Experimental Usage
,log-rank Mantel-Cox test,Analysis Software,,,,,,,,PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,Kaplan-Meier plots were generated in GraphPad Prism and p-values were determined by log-rank Mantel-Cox test.,0.9,Accept,Experimental Usage
,spatial transcriptomics profiling,Analysis Software,,,,,,,,PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,"For patients in the institutional cohort whose samples underwent bulk RNA sequencing, whole exome sequencing and spatial transcriptomics profiling",0.9,Accept,Experimental Usage
,TRAP (Tiled Regression Analysis Package),Analysis Software,,,,,,,,PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"""Tiled Regression"" as implemented in TRAP (Tiled Regression Analysis Package) was used to identify the set of independent significant variants",0.9,Accept,Experimental Usage
,GenomeStudio (v. 2010.2),Analysis Software,v. 2010.2,,,,,,,PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,SNP-array analysis was done according to the manufacturer's protocol using GenomeStudio (v. 2010.2) software,0.9,Accept,Experimental Usage
,MaxQuant version 1.6.10.43,Analysis Software,1.6.10.43,,,,,,,PMID:36890585 | PMID:33442015,10.1186/s40478-023-01525-w | 10.1038/s41591-020-01193-6,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,MaxQuant version 1.6.10.43 [ 12 ] was used whilst enabling TMTpro 16-plex reporter ion quantitation | Raw files were processed for label-free quantification by MaxQuant (version 1.6.10.43) LFQ using the Uniprot/Swiss-Prot mouse database,0.95,Accept,Experimental Usage
,Perseus (version 1.6.10.50),Analysis Software,1.6.10.50,,,,,,,PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,LFQ intensities for kinases with at least two peptides were imported into Perseus (version 1.6.10.50),0.9,Accept,Experimental Usage
,FlowJo Software (version 9.9.6),Analysis Software,9.9.6,,,,,,,PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Data were acquired uncompensated and exported as FCS 3.0 files for analysis using FlowJo Software (version 9.9.6,Tree Star Inc)",0.9,Accept,Experimental Usage
,ImageJ (version 1.47),Analysis Software,1.47,,,,,,,PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,AXL immunohistochemistry was analyzed using the IHC Profiler plugin for ImageJ (version 1.47),0.9,Accept,Experimental Usage
,HALO Image Analysis Software (version 2.3),Analysis Software,2.3,,,,,,,PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"representative image were generated using HALO Image Analysis Software (version 2.3, Indica Labs)",0.9,Accept,Experimental Usage
,XCELLigence Real Time Cell Analysis System,Analysis Software,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The microelectronic biosensor XCELLigence Real Time Cell Analysis System (RTCA, Roche Diagnostics GmbH",0.9,Accept,Experimental Usage
,Primer 3.0,Analysis Software,3.0,,,,,,,PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,Primers were designed based on the mutation sites found using Primer 3.0,0.85,Accept,Experimental Usage
,Feature Extraction 10.5,Analysis Software,10.5,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Copy number estimates were extracted from the microarray image files using Feature Extraction 10.5 (Agilent),0.85,Accept,Experimental Usage
,Agilent Genomic Workbench 6.5,Analysis Software,6.5,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,data were analyzed in Agilent Genomic Workbench 6.5 (Agilent),0.85,Accept,Experimental Usage
,Drop-seq tools (version 1.12),Analysis Software,1.12,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"FASTQ sequencing reads were processed, aligned to the mouse genome (mm10), and converted to digital gene expression matrices using the Drop-seq tools (version 1.12)",0.9,Accept,Experimental Usage
,Cellranger v5.0.1,Analysis Software,v5.0.1,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For 10X Genomics datasets, we used Cellranger v5.0.1 to align reads to the hg19 human reference sequence",0.9,Accept,Experimental Usage
,Seurat (version 3.1.0),Package/Library,3.1.0,R,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For each sample dataset, unsupervised clustering was performed using R package Seurat (version 3.1.0)",0.9,Accept,Experimental Usage
,scREF,Analysis Software,,,https://github.com/jumphone/scRef/archive/master.zip,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,scREF is a reference-based toolkit for single-cell analysis for mapping a query RNA-seq dataset onto a reference,0.85,Accept,Experimental Usage
,CIBERSORTx,Analysis Software,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,We used CIBERSORTx to perform deconvolution analysis of bulk tumor data against Lats1/2-mut advanced SN tumor cell types,0.9,Accept,Experimental Usage
,inferCNV,Analysis Software,,,,,,,,PMID:36322658 | PMID:33591953,10.1126/sciadv.abo5442 | 10.1172/jci.insight.146351,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Malignant cells were identified by inferring large-scale chromosomal CNVs in each single cell based on a moving averaged expression profiles across chromosomal intervals by inferCNV | Copy number variations of each PDX were inferred from scRNA-seq using the R package inferCNV,0.9,Accept,Experimental Usage
,VECTOR,Analysis Software,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Cell-state transition directions were inferred by VECTOR based on the observation that quantile polarization of a cell's principal component values,0.9,Accept,Experimental Usage
,Slingshot,Package/Library,,R,,,,,,PMID:36322658 | PMID:41591566,10.1126/sciadv.abo5442 | 10.1007/s00401-026-02979-7,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Slingshot is a top performer for cellular trajectory from scRNA-seq data. We used Slingshot to model the pseudotime trajectory | To explore differentiation trajectories among tumor clusters, we applied Slingshot (Version: 2.12.0)",0.9,Accept,Experimental Usage
,CytoTRACE version 0.3.3,Package/Library,0.3.3,R,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,we used the R package CytoTRACE version 0.3.3 to predict differentiation status of SC lineage cells from mouse and human scRNA-seq data,0.9,Accept,Experimental Usage
,ArchR,Package/Library,,R,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"ArchR was used for all scATAC-seq analyses according to default parameters, including quality control and cell filtering",0.9,Accept,Experimental Usage
,CellChat,Package/Library,,R,,,,,,PMID:36322658 | PMID:38907342,10.1126/sciadv.abo5442 | 10.1186/s40478-024-01821-z,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"We used CellChat to infer the intercellular communication from scRNA-seq data for further data exploration, analysis, and visualization | After processing our snRNA-seq dataset in Seurat, downstream analysis in CellChat was conducted",0.9,Accept,Experimental Usage
,DGIdb (version 3.0.2),Database,3.0.2,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"were used to query the Washington University DGIdb (version 3.0.2), with a focus on expert-curated collections of druggable genes",0.9,Accept,Experimental Usage
,Trim Galore (version 0.6.10),Analysis Software,0.6.10,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The raw sequence reads were first trimmed using Trim Galore (version 0.6.10) to remove any primer adapter contamination,0.9,Accept,Experimental Usage
,Broad's Genome Analysis ToolKit (version 4.6.0),Analysis Software,4.6.0,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The trimmed sequence reads were further analyzed using Broad's Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines,0.9,Accept,Experimental Usage
,BWA (version 0.7.17-r1188),Analysis Software,0.7.17-r1188,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle,0.9,Accept,Experimental Usage
,Picard tools (version 3.2.0),Analysis Software,3.2.0,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied,0.9,Accept,Experimental Usage
,ReAdW v. 3.5.1,Analysis Software,3.5.1,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The XCalibur RAW files were collected in profile mode, centroided and converted to MzXML using ReAdW v. 3.5.1",0.9,Accept,Experimental Usage
,MzXML2Search (included in TPP v. 3.5),Analysis Software,3.5,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The mgf files were then created using MzXML2Search (included in TPP v. 3.5) for all scans,0.9,Accept,Experimental Usage
,"Scaffold (Protein Sciences, Portland Oregon)",Analysis Software,,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The list of peptide IDs generated based on SEQUEST or MASCOT search results were filtered separately using Scaffold (Protein Sciences, Portland Oregon)",0.9,Accept,Experimental Usage
,Human Protein Atlas (proteinatlas.org),Database,23.0,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Subcellular localization was assessed for the PPI's using the Human Protein Atlas (proteinatlas.org) Subcellular section (Protein Atlas version 23.0),0.9,Accept,Experimental Usage
,QIAGEN Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Further Pathway analysis was conducted using QIAGEN Ingenuity Pathway Analysis (IPA),0.9,Accept,Experimental Usage
,GraphPad Prism V9,Analysis Software,V9,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,All graphs and statistical analyses were performed using GraphPad Prism V9,0.85,Accept,Experimental Usage
,Partek Flow software (v.9.0),Analysis Software,v.9.0,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"The analysis for this Article was generated using Partek Flow software, v.9.0",0.9,Accept,Experimental Usage
,STAR (v.2.7.3a),Analysis Software,v.2.7.3a,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR v.2.7.3a,0.9,Accept,Experimental Usage
,ImageJ (v.2.0.0),Analysis Software,v.2.0.0,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and quantified using ImageJ (v.2.0.0),0.9,Accept,Experimental Usage
,Cell Profiler (v.3.1.9),Analysis Software,v.3.1.9,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Cell proliferation was determined by dividing the number of EdU+ cells by the number of DAPI+ cells using Cell Profiler (v.3.1.9),0.9,Accept,Experimental Usage
,Stereo Investigator software (mbfbioscience v2019),Analysis Software,v2019,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and the Stereo Investigator software (mbfbioscience v2019),0.9,Accept,Experimental Usage
,Image Lab software (v.6),Analysis Software,v.6,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,imaged on a Bio-Rad Gel Doc imager using Image Lab software (v.6),0.9,Accept,Experimental Usage
,Image Studio Lite (v.5.0.21),Analysis Software,v.5.0.21,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,and analysed using Image Studio Lite (v.5.0.21),0.9,Accept,Experimental Usage
,origin8.1,Analysis Software,8.1,,,,,,,PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.85,Accept,Experimental Usage
,Nikon Elements software,Analysis Software,,,,,,,,PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,The morphometric analysis of neurite lengths of transfected green fluorescent cells was performed with Nikon Elements software,0.9,Accept,Experimental Usage
,BWA-MEM v 0.7.12,Command-line Tool,v 0.7.12,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,read pairs were aligned to the hg19 reference genome using BWA-MEM v 0.7.12 with default parameters,0.9,Accept,Experimental Usage
,GATK v3.6.0,Command-line Tool,v3.6.0,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0",0.9,Accept,Experimental Usage
,Mutect V1.1.6,Command-line Tool,V1.1.6,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage
,Strelka v1.0.13,Command-line Tool,v1.0.13,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage
,STAR aligner (v.2.6.0),Command-line Tool,v.2.6.0,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Sequence data was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0),0.9,Accept,Experimental Usage
,FusionCatcher v1.1.0,Command-line Tool,v1.1.0,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Fusion genes for cohort of PNSTs were identified using FusionCatcher v1.1.0 with default parameters,0.9,Accept,Experimental Usage
,Seurat version 3.0,Package/Library,version 3.0,R,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"The raw gene expression matrix was normalized, and variance stabilized by SCTransform in Suerat version 3.0",0.9,Accept,Experimental Usage
,inferCNV (v.1.1.1),Package/Library,v.1.1.1,R,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,CNAs of neoplastic and non-neoplastic cells were inferred from the snRNA-seq data using inferCNV (v.1.1.1),0.9,Accept,Experimental Usage
,Affymetrix GeneChip Mouse Genome 430 2.0 Array,Analysis Software,,,,,,,,PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Mouse optic glioma neurospheres, Nf1−/− TVZ NSCs (TVZ_Cre) and wild-type TVZ NSCs (TVZ_LacZ) RNA was subjected to Affymetrix GeneChip Mouse Genome 430 2.0 Array hybridization",0.9,Accept,Experimental Usage
,Partex Genomics Suite Version 6.6 beta,Analysis Software,6.6 beta,,,,,,,PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,the resulting data analyzed using Partex Genomics Suite Version 6.6 beta,0.9,Accept,Experimental Usage
,pheatmap package,Package/Library,,R,http://cran.r-project.org/web/packages/pheatmap/index.html,,,,,PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,The heatmap was generated using CRAN's pheatmap package ( http://cran.r-project.org/web/packages/pheatmap/index.html ),0.8,Accept,Experimental Usage
,limma package,Package/Library,,R,,,,,,PMID:23175151 | PMID:34010628 | PMID:28256556 | PMID:23535903,10.1038/bjc.2012.518 | 10.1016/j.stem.2021.04.029 | 10.1038/srep43315 | 10.1158/2159-8290.CD-13-0081,"MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,The limma package was also used for differential expression and multiple testing was controlled using the false discovery rate | Limma package was used for generating the human 621-MPNST signature | The Bioconductor/R limma package was used to define DEGs between two groups | Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ),0.9,Accept,Experimental Usage
,GeneSpring GX v7.3.1,Analysis Software,v7.3.1,,,,,,,PMID:23685747 | PMID:23535903,10.1038/ng.2641 | 10.1158/2159-8290.CD-13-0081,"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor packages and GeneSpring GX v7.3.1 (Agilent Technologies) | Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ) and GeneSpring GXv7.3.1 (Agilent Technologies),0.9,Accept,Experimental Usage
,CalcuSyn Version 2.1,Analysis Software,2.1,,,,,,,PMID:24681606 | PMID:23535903,10.18632/oncotarget.1609 | 10.1158/2159-8290.CD-13-0081,"Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"All data analysis was done using Calcusyn software (CalcuSyn Version 2.1, BioSoft)",0.9,Accept,Experimental Usage
,"Matlab script (Version 9.9.0, Natick, MA)",Analysis Software,9.9.0,MATLAB,,,,,,PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"The SSTMean method consisted of 4 main steps that were implemented in a Matlab script (Version 9.9.0, Natick, MA).",0.85,Accept,Development
,SSTMean,Analysis Software,,,,,,,,PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,A semi-automatic segmentation technique based on mean magnetic resonance imaging (MRI) intensity thresholding (SSTMean) was developed,0.9,Accept,Development
,fastp v.0.2,Analysis Software,v.0.2,,,,,,,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,raw reads were quality filtered using fastp v.0.2,0.9,Accept,Experimental Usage
,BWA v.0.7.17,Analysis Software,v.0.7.17,,,,,,,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17,0.9,Accept,Experimental Usage
,Samtools v.1.7,Analysis Software,v.1.7,,,,,,,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Aligned reads were deduplicated with Samtools v.1.7,0.9,Accept,Experimental Usage
,ichorCNA tool (Broad v.0.2.0),Analysis Software,v.0.2.0,,,,,,,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,copy number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0),0.95,Accept,Experimental Usage
,deepTools bamPEFragmentSize,Analysis Software,,,,,,,,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,read-pair fragment sizes for cfDNA samples were calculated using deepTools bamPEFragmentSize,0.9,Accept,Experimental Usage
,CRISPOR software,Web Application,,,http://crispor.tefor.net,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Single-guide RNAs (sgRNAs) were designed using CRISPOR software (http://crispor.tefor.net),0.9,Accept,Experimental Usage
,AnyMaze software,Analysis Software,,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,The time spent near each wire cup was recorded and scored with the automated AnyMaze software,0.9,Accept,Experimental Usage
,GraphPad Prism version 5.0d,Analysis Software,5.0d,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,Analysis was performed using GraphPad Prism version 5.0d (GraphPad Software),0.9,Accept,Experimental Usage
,Origin® 8,Analysis Software,8,,,,,,,PMID:35393510 | PMID:35614131,10.1038/s41418-022-00991-4 | 10.1038/s41418-022-01020-0,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,"Statistical significance was determined using Origin® 8 (OriginLab, Northampton, MA) | Statistical significance was determined using Origin ® 8 (OriginLab, Northampton, MA)",0.9,Accept,Experimental Usage
,Prism 6.0,Analysis Software,6.0,,,,,,,PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,Protein quantification and assessment of significance was determined in Prism 6.0,0.85,Accept,Experimental Usage
,SPSS 18,Analysis Software,18,,,,,,,PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA)",0.9,Accept,Experimental Usage
,SAS 9.3,Analysis Software,9.3,,,,,,,PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA) and SAS 9.3 version for Windows (SAS Institute Inc., Cary, NC, USA)",0.9,Accept,Experimental Usage
,UCSF500 NGS Panel,Analysis Software,,,,,,,,PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Targeted next-generation sequencing was performed using the UCSF500 NGS Panel as previously described,0.9,Accept,Experimental Usage
,Rtsne,Package/Library,v.0.15,R,,,,,,PMID:35945463 | PMID:33025139,10.1007/s00401-022-02478-5 | 10.1007/s00401-020-02230-x,"Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Dimensionality reduction using t-distributed stochastic neighbor embedding (tSNE) was performed by Rtsne (v.0.15) | We used Rtsne package in Bioconductor to generate tSNE plots based on the top 10,000 most variably methylated CpG sites",0.9,Accept,Experimental Usage
,ComplexHeatmap,Package/Library,v.2.8.0,R,,,,,,PMID:35945463 | PMID:39093127,10.1007/s00401-022-02478-5 | 10.1158/1078-0432.CCR-24-0797,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,Visualization was performed using the R package ComplexHeatmap (v.2.8.0) | were represented by heatmaps using ComplexHeatmap (v.2.14.0) with supervised clustering,0.9,Accept,Experimental Usage
,Prism 4.0,Analysis Software,4.0,,,,,,,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Graphing and statistical analysis was performed with Prism 4.0 (GraphPad Software, La Jolla, CA)",0.85,Accept,Experimental Usage
,Feature extractionTM software,Analysis Software,9.5.1.1,,,,,,,PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"microarray images were automatically analysed using Feature extractionTM software, version 9.5.1.1 (Agilent Technologies)",0.9,Accept,Experimental Usage
,Filtlong v0.2.0,Command-line Tool,v0.2.0,,https://github.com/rrwick/Filtlong,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,ONT reads meeting a minimum Q-value of 10 were size- and chimera-filtered with Filtlong v0.2.0,0.9,Accept,Experimental Usage
,Porechop v0.2.4,Command-line Tool,v0.2.4,,https://github.com/rrwick/Porechop,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,ONT reads meeting a minimum Q-value of 10 were size- and chimera-filtered with Filtlong v0.2.0 and Porechop v0.2.4,0.9,Accept,Experimental Usage
,Flye v2.5,Analysis Software,v2.5,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Filtered reads were assembled with Flye v2.5, enforcing a 10,000 bp overlap minimum",0.9,Accept,Experimental Usage
,GCpp v1.0.0-1807624,Analysis Software,v1.0.0-1807624,,https://github.com/PacificBiosciences/gcpp,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Approximately 20× PacBio subread coverage was used with GCpp v1.0.0-1807624 to independently error-correct the ONT-based Flye assembly,0.9,Accept,Experimental Usage
,purge_haplotigs,Command-line Tool,,,https://bitbucket.org/mroachawri/purge_haplotigs/src/master/,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The resulting error-corrected haploid assembly was deduplicated with purge_haplotigs commit be7e44b,0.9,Accept,Experimental Usage
,Juicer v1.6.2,Analysis Software,v1.6.2,,https://github.com/aidenlab/juicer,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Juicer v1.6.2 and 3D-DNA v180114 were used to scaffold the deduplicated, error-corrected assembly with the Hi-C data",0.9,Accept,Experimental Usage
,3D-DNA v180114,Analysis Software,v180114,,https://github.com/aidenlab/3d-dna,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Juicer v1.6.2 and 3D-DNA v180114 were used to scaffold the deduplicated, error-corrected assembly with the Hi-C data",0.9,Accept,Experimental Usage
,BUSCO v5.7.0,Analysis Software,v5.7.0,,https://busco.ezlab.org/,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,We assessed the quality of our genome assembly using BUSCO v5.7.0 with mammalia_odb10,0.9,Accept,Experimental Usage
,QUASTv5.0.2,Analysis Software,v5.0.2,,https://quast.sourceforge.net/,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,We assessed the quality of our genome assembly using BUSCO v5.7.0 with mammalia_odb10 and QUASTv5.0.2,0.9,Accept,Experimental Usage
,Liftoff v1.6.3,Analysis Software,v1.6.3,,https://github.com/agshumate/Liftoff,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Putative genes in the WMSTM draft genome were identified using Liftoff v1.6.3 with default parameters,0.9,Accept,Experimental Usage
,SnapGeneTM Version 7.2.1,Analysis Software,7.2.1,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,aligned it to the S. scrofa reference coding sequence using the align sequences feature in SnapGeneTM Version 7.2.1,0.9,Accept,Experimental Usage
,AlphaFold 3,Web Application,,,,,,,,PMID:40191916 | PMID:39373898,10.1093/g3journal/jkaf067 | 10.1007/s12031-024-02271-x,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool. | Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.",,"The WMSTM and human amino acid sequences were then input into AlphaFold 3 for structural predictions | we utilized AlphaFold3 to simulate both the wild-type and mutant NF1 structures, revealing the significant effects",0.9,Accept,Experimental Usage
,PyMOL Version 3.0.5,Analysis Software,3.0.5,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"The structural predictions from WMSTM and human proteins were aligned using PyMOL (The PyMOL Molecular Graphics System, Version 3.0.5 Schrödinger, LLC.)",0.9,Accept,Experimental Usage
,Skewer v0.2.2.b,Command-line Tool,v0.2.2.b,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Adapters, low-quality bases, and primers were trimmed from reads to obtain a Phred score of 20 via the trimming software Skewer (v0.2.2.b)",0.9,Accept,Experimental Usage
,Tassel pipeline version 2,Pipeline,version 2,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The Tassel pipeline (version 2) was used to process sequence reads to single nucleotide polymorphism (SNP) genotypes,0.9,Accept,Experimental Usage
,VCFtools v.0.1.16,Command-line Tool,v.0.1.16,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The population-wide inbreeding coefficient F was calculated with VCFtools (v.0.1.16),0.9,Accept,Experimental Usage
,Beagle v4.1,Analysis Software,v4.1,,,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Beagle v4.1 was used to perform whole genome phasing and to impute missing data,0.9,Accept,Experimental Usage
,itol v6.9.1,Web Application,v6.9.1,,https://itol.embl.de/,,,,,PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,A mid-point rooted topology was created from the VCF data using RAxML and visualized with itol v6.9.1,0.9,Accept,Experimental Usage
,Smart-seq2,Pipeline,,,,,,,,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"Smart-seq2 whole transcriptome amplification, library construction, and sequencing were performed as previously published",0.9,Accept,Experimental Usage
,scdDblFinder,Package/Library,,R,,,,,,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Doublets were identified by combining the results of two methods that were published recently and implemented in R packages—scdDblFinder,0.9,Accept,Experimental Usage
,scran,Package/Library,,R,,,,,,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,scdDblFinder and the doubletCells algorithm from scran,0.9,Accept,Experimental Usage
,QuPath,Analysis Software,,,,,,,,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Quantification of staining intensity was performed in QuPath,0.9,Accept,Experimental Usage
,GENIE (Genomics Evidence Neoplasia Information Exchange),Database,v.7.0,,,,,,,PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,cancer genomics databases including GENIE (Genomics Evidence Neoplasia Information Exchange),0.9,Accept,Experimental Usage
,cBioPortal,Web Application,,,,,,,,PMID:33507258 | PMID:39472976 | PMID:41564118,10.1001/jamanetworkopen.2020.35479 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,databases in cBioPortal including TCGA (The Cancer Genome Atlas) | The cBioportal website (cbioportal.org) was used to analyze The Cancer Genome Atlas (TCGA)—Firehose Legacy | Somatic variants were queried in cBioPortal (https://www.cbioportal.org/),0.9,Accept,Experimental Usage
,TCGA (The Cancer Genome Atlas),Database,,,,,,,,PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,databases in cBioPortal including TCGA (The Cancer Genome Atlas),0.9,Accept,Experimental Usage
,Seurat,Package/Library,5.3.0,R,https://satijalab.org/seurat/,,,,,PMID:41591566 | PMID:33591953 | PMID:38216587,10.1007/s00401-026-02979-7 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"We processed the data using Seurat (Version: 5.3.0, https://satijalab.org/seurat/) in R (Version: 4.4.0) | filtered_feature_bc_matrix was imported using the Read10X function in Seurat (version 3.0) | Data were normalized, and variance stabilized by SCTransform in Seurat version 3.0",0.95,Accept,Experimental Usage
,CellRanger,Analysis Software,,,,,,,,PMID:37770931 | PMID:33591953 | PMID:38216587,10.1186/s40478-023-01639-1 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,"Raw sequencing reads were processed using CellRanger (10 × Genomics) | The standard 10X Genomics Cell Ranger (version 3.1.0) pipeline was used to extract FASTQ files | Library demultiplexing, read alignment to human genome GRCh38, and unique molecular identifier (UMI) quantification was performed in Cell Ranger version 1.3.1",0.9,Accept,Experimental Usage
,Signac,Package/Library,1.8.0,R,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Preprocessing of single-nuclei RNA and ATAC data was performed using Signac v1.8.0,0.85,Accept,Experimental Usage
,caret,Package/Library,6.0,R,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,a methylation-based classifier using differentially methylated probes from our discovery cohort of 66 tumors was used to construct a support vector machine (SVM) using caret version 6.0 in R version 3.6.0,0.85,Accept,Experimental Usage
,Aardex MEMS Adherence Software (ElectronReader 0.9.9),Analysis Software,0.9.9,,,,,,,PMID:39858077,10.3390/cancers17020295,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,,"diaries and pill bottles (including empty ones) were collected, and MEMS TM cap data were uploaded to Aardex MEMS TM Adherence Software (ElectronReader 0.9.9).",0.85,Accept,Experimental Usage
,NanoDrop 2000,Analysis Software,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Purity of DNA was assessed by spectrophotometry using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage
,Ion Torrent Personal Genome Machine—Ion Torrent PGM™,Analysis Software,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,NGS was performed on Ion Torrent Personal Genome Machine—Ion Torrent PGM™ (Thermo Fisher Scientific),0.95,Accept,Experimental Usage
,Torrent Suite software,Analysis Software,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Primary analyses of NGS data were performed using Torrent Suite software on the Ion Torrent Browser,0.9,Accept,Experimental Usage
,Ingenuity Variant Analysis software,Analysis Software,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used",0.9,Accept,Experimental Usage
,Integrative Genomics Viewer,Analysis Software,2.3.40,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Variants were also viewed manually on Integrative Genomics Viewer (IGV—version 2.3.40; Broad Institute, Cambridge, MA, USA)",0.9,Accept,Experimental Usage
,Alamut Visual,Analysis Software,2.6.1e,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"on Alamut ® Visual (version 2.6.1e; Interactive Biosoftware, Rouen, France) to eliminate strand bias and reduce false positive calls",0.9,Accept,Experimental Usage
,Human Splicing Finder,Web Application,,,,,,,,PMID:40887659 | PMID:27999334,10.1186/s40246-025-00803-z | 10.3390/genes7120133,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity. | Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,with the Human Splicing Finder (HSF; http://www.umd.be/HSF/) | we also used the online Human Splicing Finder ( http://www.umd.be/HSF/ ),0.9,Accept,Experimental Usage
,AB3130 Genetic Analyzer,Analysis Software,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"All variants were confirmed by Sanger sequencing in an AB3130 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA)",0.9,Accept,Experimental Usage
,Sequencing Analysis software,Analysis Software,5.4,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,the sequences were analyzed with the Sequencing Analysis software (version 5.4; Applied Biosystems),0.85,Accept,Experimental Usage
,FlowJo 7.6.5,Analysis Software,7.6.5,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.9,Accept,Experimental Usage
,"ImageJ software v.1.49 (NIH, USA)",Analysis Software,v.1.49,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Images were analyzed using ImageJ software v.1.49 (NIH, USA), and the percentage of stained area in each picture was obtained...",0.9,Accept,Experimental Usage
,SPSS v. 20.0,Analysis Software,v. 20.0,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Statistical analysis was performed using Statistical Package for Social Sciences software (SPSS v. 20.0; Chicago, IL, USA)...",0.8,Accept,Experimental Usage
,Karyostudio 1.3 software,Analysis Software,1.3,,,,,,,PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,The analysis was performed using the Karyostudio 1.3 software (Illumina),0.85,Accept,Experimental Usage
,Partek Flow software,Analysis Software,v10.0,,,,,,,PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"RNA sequencing analysis was generated using Partek Flow software, v10.0",0.9,Accept,Experimental Usage
,Imaris software,Analysis Software,9,,,,,,,PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Images were 3D-rendered using Imaris software (Imaris 9, Oxford Instruments, Abingdon, UK)",0.9,Accept,Experimental Usage
,ChAMP,Package/Library,v2.18.3,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Data were analyzed using a modified workflow that is similar to the ChAMP methylation array analysis procedure in R (v3.5.1),0.9,Accept,Experimental Usage
,glmmTMB,Package/Library,v0.2.2,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated loci between cutaneous and plexiform neurofibromas were identified using a hierarchical generalized linear mixed model (GLMM) approach with a logit link function as implemented in glmmTMB (v0.2.2),0.85,Accept,Experimental Usage
,DMRcate,Package/Library,v1.18.0,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated regions were called using DMRcate (v1.18.0),0.85,Accept,Experimental Usage
,compartmap,Package/Library,v1.65.71,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Chromatin compartments were computed at 100 kb resolution as previously described and implemented in compartmap (v1.65.71),0.85,Accept,Experimental Usage
,missMethyl,Package/Library,v1.16.0,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Enrichment of pathways and gene ontology (GO) terms was performed using the gometh function within the missMethyl (v1.16.0) package in R,0.85,Accept,Experimental Usage
,PAMES,Package/Library,v0.2.3,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Tissue purity was estimated by PAMES (v0.2.3),0.85,Accept,Experimental Usage
,SeSAMe,Package/Library,v1.3.2,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Copy number alterations were computed using SeSAMe (v1.3.2) with minor modifications for plotting functionality,0.85,Accept,Experimental Usage
,betareg,Package/Library,v3.1-2,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2),0.85,Accept,Experimental Usage
,emmeans,Package/Library,v1.4.2,R,,,,,,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2) were done using emmeans (v1.4.2),0.85,Accept,Experimental Usage
,MACS version 1.4.2,Analysis Software,1.4.2,,,,,,,PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,peak calling was performed using Model-based analysis of ChIP-seq (MACS) version 1.4.2 ( http://liulab.dfci.harvard.edu/MACS ) with default parameters,0.9,Accept,Experimental Usage
,3D Slicer,Analysis Software,5.6.2,,https://www.slicer.org/,,,,,PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"The two readers independently performed three-dimensional selection of the volume of interest by manual segmentation of the DRG of levels L5 and S1 via 3D Slicer (The Slicer Community 2024: 3D Slicer, version 5.6.2)",0.9,Accept,Experimental Usage
,SPSS 25,Analysis Software,25,,,,,,,PMID:34646065,10.1155/2021/9386823,Survival and ,,"All data were analyzed using statistical software (SPSS 25, IBM Co. Armonk, NY)",0.8,Accept,Experimental Usage
,SimNIBS 3.2,Analysis Software,3.2,,https://simnibs.github.io/simnibs/build/html/index.html,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,SimNIBS 3.2 ( https://simnibs.github.io/simnibs/build/html/index.html ) was used to estimate the electric field induced by tDCS,0.9,Accept,Experimental Usage
,SPM8,Analysis Software,8,,http://www.fil.ion.ucl.ac.uk/spm/,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"the T1-weighted anatomical images were segmented into gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) using SPM8",0.9,Accept,Experimental Usage
,jMRUI5.1,Analysis Software,5.1,,,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Quantification was conducted using the Advanced Magnetic Resonance (AMARES) routine in the Java-based magnetic resonance user's interface (jMRUI5.1, EU project)",0.9,Accept,Experimental Usage
,SPM12,Analysis Software,12,,http://www.fil.ion.ucl.ac.uk/spm,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London)",0.9,Accept,Experimental Usage
,Psychopy2,Analysis Software,2,,,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Psychopy2 software was used to display the stimuli and to record responses,0.85,Accept,Experimental Usage
,SPSS version25,Analysis Software,25,,,,,,,PMID:36316421 | PMID:33519543 | PMID:37608248,10.1038/s41598-022-21907-9 | 10.3389/fpsyt.2020.585700 | 10.1186/s11689-023-09492-y,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1. | Autism Spectrum Disorder Symptom Profile Across the RASopathies. | Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,"Statistical analyses were performed in SPSS version25 and R version 1.2 | Data were analyzed in SPSS version 25 (SPSS Inc., Chicago, USA) | Statistical analyses were conducted using SPSS (Version 25)",0.85,Accept,Experimental Usage
,R version 1.2,Analysis Software,1.2,R,,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Statistical analyses were performed in SPSS version25 and R version 1.2,0.85,Accept,Experimental Usage
,MATLAB R2014a,Analysis Software,R2014a,MATLAB,,,,,,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London; http://www.fil.ion.ucl.ac.uk/spm ) and MATLAB R2014a",0.85,Accept,Experimental Usage
,Imaris × 64 version 9.6–9.9,Analysis Software,9.6–9.9,,,,,,,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"3-dimensional fluorescence images using Imaris × 64 version 9.6–9.9 (Bitplane, Zurich, Switzerland) algorithms",0.95,Accept,Experimental Usage
,IGOR Pro 6.37,Analysis Software,6.37,,,,,,,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"IGOR Pro 6.37 (Lake Oswego, USA) was used for data analysis",0.9,Accept,Experimental Usage
,Prism 7,Analysis Software,7,,,,,,,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"one-way ANOVA tests with Bonferroni post hoc tests were employed using Prism 7 (GraphPad Software, San Diego, CA, USA)",0.9,Accept,Experimental Usage
,wANNOVAR web server,Web Application,,,,,,,,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We used wANNOVAR web server to annotate and prioritize variants, identified candidate genes with recurrent mutations",0.9,Accept,Experimental Usage
,SeqMule,Pipeline,,,http://seqmule.usc.edu/,,,,,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We used SeqMule (http://seqmule.usc.edu/) pipeline as our primary variant calling pipeline.,0.9,Accept,Experimental Usage
,Codon Code Aligner,Analysis Software,,,http://www.codoncode.com/aligner/,,,,,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,The sequencing traces were manually visualized in Codon Code Aligner software (http://www.codoncode.com/aligner/) to confirm the presence of candidate mutations.,0.85,Accept,Experimental Usage
,primer 3 (v. 0.4.0),Web Application,v. 0.4.0,,http://bioinfo.ut.ee/primer3-0.4.0/,,,,,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,Twelve pairs of primers were designed using primer 3 (v. 0.4.0) (http://bioinfo.ut.ee/primer3-0.4.0/).,0.9,Accept,Experimental Usage
,Stratagene Mx3005 – MxPro QPCR-Software,Analysis Software,2007,,,,,,,PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system in the allelic discrimination mode (Stratagene Mx3005 – MxPro QPCR-Software, 2007)",0.8,Accept,Experimental Usage
,SPSS 20.0,Analysis Software,20.0,,,,,,,PMID:32733557 | PMID:27458360,10.1155/2020/5976465 | 10.3389/fnhum.2016.00334,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis. | COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.",,Statistical analysis was conducted by SPSS 20.0 software. | All statistical procedures were performed in SPSS 20.0,0.8,Accept,Experimental Usage
,Incucyte S3 Live-Cell Analysis System,Analysis Software,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The total integrated intensity of RFP was monitored over the course of 72 hours, taking measurements every 2 hours with the Incucyte S3 Live-Cell Analysis System (Sartorius, Gottingen, Germany)",0.9,Accept,Experimental Usage
,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",Analysis Software,1.1,,,,,,,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"cDNA samples were then subjected to qPCR amplification on an ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",0.85,Accept,Experimental Usage
,Python version 3.10,Analysis Software,3.10,Python,,,,,,PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,,"All statistics and models were conducted in Python version 3.10 (Python Software Foundation, Wilmington, Delaware, US).",0.8,Accept,Experimental Usage
,SPSS 17.0,Analysis Software,17.0,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Statistical analysis was performed using the SPSS 17.0 statistics software,0.8,Accept,Experimental Usage
,SPSS 12.0,Analysis Software,12.0,,,,,,,PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,"All data were analyzed using SPSS 12.0 (SPSS Inc, Chicago, Illinois)",0.8,Accept,Experimental Usage
,Mutalyzer 2.0,Web Application,2.0,,,,,,,PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...the online batch position check tool Mutalyzer 2.0 (http://www.mutalyzer.nl/) was used to confirm genomic position of all SPRED1 gene variants...,0.9,Accept,Experimental Usage
,FusionCharts v3,Analysis Software,v3,,,,,,,PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...Graphics were generated using FusionCharts v3 (www.fusioncharts.com)...,0.9,Accept,Experimental Usage
,DESeq2 (version 1.12.4),Package/Library,1.12.4,R,,,,,,PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples,0.9,Accept,Experimental Usage
,PRISM (version 8),Analysis Software,8,,,,,,,PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"Statistical analyses were conducted with PRISM (version 8, GraphPad Software, Inc., San Diego, CA, USA)",0.8,Accept,Experimental Usage
,Volocity software (Version 7.0.0),Analysis Software,7.0.0,,,,,,,PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Image stacks were processed and reconstructed in 3D using Volocity software (Version 7.0.0; PerkinElmer, Waltham, MA, USA) for visualization and quantification",0.9,Accept,Experimental Usage
,ImageJ 1.54g software,Analysis Software,1.54g,,,,,,,PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Fluorescence intensity of P-glycoprotein was quantified using ImageJ 1.54g software (National Institutes of Health, Bethesda, MD, USA).",0.85,Accept,Experimental Usage
,Insight Toolkit,Package/Library,,,www.itk.org/,,,,,PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,The pipeline for PN identification was developed in-house using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite,0.85,Accept,Experimental Usage
,Slicer,Analysis Software,,,www.slicer.org/,,,,,PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite, Slicer ( www.slicer.org/ )",0.85,Accept,Experimental Usage
,RELION,Analysis Software,,C++,,,,,,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Data processing was done using the RELION (32) software package.,0.9,Accept,Experimental Usage
,bwa-mem v0.7.10,Analysis Software,v0.7.10,,,,,,,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Sequence reads were aligned to the reference sequence (GRCh37) using bwa‐mem v0.7.10,0.95,Accept,Experimental Usage
,"GATK, version 1.0.4705",Analysis Software,1.0.4705,,,,,,,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"followed by variant calling using GATK, version 1.0.4705",0.95,Accept,Experimental Usage
,VisCap,Analysis Software,,,,,,,,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Copy number variants (CNVs) were identified via an NGS‐based detection tool (VisCap),0.9,Accept,Experimental Usage
,Trimmomatic v 0.39,Analysis Software,v 0.39,,,,,,,PMID:37246765 | PMID:38000020,10.1093/neuonc/noad097 | 10.1126/sciadv.adg8876,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39 | Whole-exome sequencing FastQ files were trimmed by using Trimmomatic v 0.39,0.9,Accept,Experimental Usage
,GATK V4.2,Analysis Software,V4.2,,,,,,,PMID:37246765 | PMID:38000020,10.1093/neuonc/noad097 | 10.1126/sciadv.adg8876,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files | Genomic analysis toolkit (GATK) V4.2 base quality score recalibration was also used to process BAM files,0.9,Accept,Experimental Usage
,FlowJo 10.8,Analysis Software,10.8,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Data analysis was performed using FlowJo 10.8, and cell cycle distribution was assigned by using the implemented models",0.8,Accept,Experimental Usage
,PhenoCapture 3.3,Analysis Software,3.3,,,,,,,PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Images were captured every 15 min using a time-lapse image software (PhenoCapture 3.3),0.8,Accept,Experimental Usage
,Fiji 2.0,Analysis Software,2.0,,,,,,,PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Images were captured every 15 min using a time-lapse image software (PhenoCapture 3.3) and analyzed using Fiji 2.0,0.8,Accept,Experimental Usage
,Cell Ranger pipeline v7.1.0,Pipeline,v7.1.0,,,,,,,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,resulting sequencing files were run through the Cell Ranger pipeline v7.1.0,0.9,Accept,Experimental Usage
,Seurat v4.3.0–v5,Package/Library,v4.3.0–v5,R,,,,,,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"Data analysis was completed using R (v 4.3.0–v 4.3.1) Seurat [ 24 ,  25 ] (v4.3.0–v5)",0.9,Accept,Experimental Usage
,Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,Ingenuity pathway analysis (IPA) was also used to identify pathways that differ on treatment,0.9,Accept,Experimental Usage
,Illumina CASAVA software (v1.8),Analysis Software,v1.8,,,,,,,PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"primary processing of sequence data for both tumor and normal samples were performed using Illumina CASAVA software (v1.8), including masking of adapter sequences.",0.9,Accept,Experimental Usage
,RealSeqS,Analysis Software,,,https://zenodo.org/record/3656943#.YaZZCdDMKUk.32,,,,,PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"RealSeqS uses a single primer pair to amplify about 750,000 loci scattered throughout the genome",0.9,Accept,Experimental Usage
,BWA version 0.7.15,Command-line Tool,0.7.15,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"The sequenced reads were mapped to the hg19 by Burrows-Wheeler Aligner (BWA version 0.7.15, default parameters, BWA-MEM algorithm)",0.85,Accept,Experimental Usage
,GATK MuTect2 (version 4.1),Analysis Software,4.1,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were identified via GATK MuTect2 (version 4.1, default parameters)",0.85,Accept,Experimental Usage
,ANNOVAR (version 2016-02-01),Analysis Software,2016-02-01,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were annotated with software ANNOVAR (version 2016-02-01, default parameters)",0.85,Accept,Experimental Usage
,SAS 9.4,Analysis Software,9.4,,,,,,,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"All statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC)",0.85,Accept,Experimental Usage
,ParaVision 6.0.1,Analysis Software,6.0.1,,,,,,,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"B-GA12S HP gradients running ParaVision 6.0.1, Bruker BioSpin",0.85,Accept,Experimental Usage
,Trimmomatic (v0.33),Analysis Software,v0.33,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,quality trimming via Trimmomatic (v0.33),0.85,Accept,Experimental Usage
,HISAT2 (v2.1.0),Analysis Software,v2.1.0,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,alignment via HISAT2 (v2.1.0),0.85,Accept,Experimental Usage
,StringTie (v1.3.4d),Analysis Software,v1.3.4d,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,gene count quantification via StringTie (v1.3.4d),0.85,Accept,Experimental Usage
,DESeq2 (v1.42.0),Package/Library,v1.42.0,R,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"Differential expression analysis was performed using R statistical software (v4.3.1), tidyverse (v2.0.0), and DESeq2 (v1.42.0)",0.85,Accept,Experimental Usage
,GeneAnalytics(v),Web Application,v,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Pathway analysis was performed using GeneAnalytics(v),0.8,Accept,Experimental Usage
,Bruker AutoFlex III mass spectrometer,Analysis Software,,,,,,,,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"MALDI IMS experiments were performed on a Bruker AutoFlex III mass spectrometer (Bruker Daltonics Billerica, MA, USA)",0.9,Accept,Experimental Usage
,FlexImaging 4.0,Analysis Software,4.0,,,,,,,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,The 2-D IMS data sets were collected using FlexImaging 4.0 (Bruker Daltonics),0.9,Accept,Experimental Usage
,Thermo LTQ Velos Orbitrap mass spectrometer,Analysis Software,,,,,,,,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"LC-MS/MS experiments were performed on a Thermo LTQ Velos Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage
,TagIdent,Web Application,,,http://web.expasy.org/tagident/,,,,,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,sequence tags of around 4–5 amino acids that were subsequently searched using TagIdent (http://web.expasy.org/tagident/),0.85,Accept,Experimental Usage
,protein prospector MS-product,Web Application,,,http://prospector.ucsf.edu/prospector/mshome.htm,,,,,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,Proteins with matching intact molecular weights and containing the sequence observed were processed using protein prospector MS-product (http://prospector.ucsf.edu/prospector/mshome.htm),0.85,Accept,Experimental Usage
,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0,Analysis Software,,,,,,,,PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,These microarray data were based on GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version],0.9,Accept,Experimental Usage
,Bioconductor limma package,Package/Library,,R,,,,,,PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,The Bioconductor limma package [20] was used to preprocess the expression data from Human Genome U133 Plus 2.0 Affymetrix Array,0.9,Accept,Experimental Usage
,GraphPad Prism Version 6,Analysis Software,6,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The IC50 was calculated using GraphPad Prism Version 6 (La Jolla, CA).",0.8,Accept,Experimental Usage
,Volocity software 7.0.0,Analysis Software,7.0.0,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Images were reconstructed in 3D using Volocity software 7.0.0 (PerkinElmer, Waltham, MA, USA)",0.9,Accept,Experimental Usage
,Nanoparticle Tracking Analysis software version 3.3 Dev Build 3.3.104,Analysis Software,3.3 Dev Build 3.3.104,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"sEV depletion was determined by version 3.3 Dev Build 3.3.104 Nanoparticle Tracking Analysis software (Malvern Panalytical Ltd., Malvern, UK)",0.9,Accept,Experimental Usage
,GraphPad Prism version 8.0.1,Analysis Software,8.0.1,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"The significance of differences was evaluated either by one-way ANOVA, followed by Tukey's post hoc test to correct for multiple comparisons, or by Student's t-test for two groups using GraphPad Prism version 8.0.1",0.8,Accept,Experimental Usage
,Image J software,Analysis Software,,,,,,,,PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"surface area of the tumor on each sequential image was determined using the measurement tool on Image J software (NIH, Bethesda, MD)",0.9,Accept,Experimental Usage
,GraphPad Prism 6.0,Analysis Software,6.0,,,,,,,PMID:26219339 | PMID:31527226,10.18632/oncotarget.4858 | 10.1158/1535-7163.MCT-19-0123,"A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of",,"Growth curves were plotted using GraphPad Prism 6.0 software (San Diego, CA) | GraphPad Prism 5.0 and 6.0 was used to perform all statistical analyses. Comparison of the means for nerve root volume, tumor number, KI-67 proliferation index",0.85,Accept,Experimental Usage
,Oligo 5.0 computer program,Analysis Software,5.0,,,,,,,PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"Primers for TBP, RPLP0 and the 489 target genes (List in annex; supplementary information) were chosen with the assistance of the Oligo 5.0 computer program (National Biosciences, Plymouth, MN)",0.85,Accept,Experimental Usage
,R 4.4.2 software,Analysis Software,4.4.2,R,,,,,,PMID:40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,,"Statistical analyses were performed using R 4.4.2 software (R Foundation for Statistical Computing, Vienna, Austria)",0.8,Accept,Experimental Usage
,Sci-kit Learn,Package/Library,,Python,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.9,Accept,Experimental Usage
,python 3.5.1,Analysis Software,3.5.1,Python,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.85,Accept,Experimental Usage
,Li-COR Image Studio Lite 5.0,Analysis Software,5.0,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,Densitometry was performed using Li-COR Image Studio Lite 5.0,0.9,Accept,Experimental Usage
,R version 3.2.3,Analysis Software,3.2.3,R,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We performed all preprocessing steps using R version 3.2.3,0.85,Accept,Experimental Usage
,nf1_inactivation GitHub repository,Pipeline,,,https://github.com/greenelab/nf1_inactivation,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"All source code is available under a permissive open source license in the nf1_inactivation GitHub repository, https://github.com/greenelab/nf1_inactivation",0.95,Accept,Development
,GeneChip Human Transcriptome Array 2.0,Other,,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"samples were labeled for the GeneChip Human Transcriptome Array 2.0 (HTA 2.0, Affymetrix)",0.9,Accept,Experimental Usage
,BioNavigator software V.6.3,Analysis Software,V.6.3,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,software-based image analysis (BioNavigator software V.6.3 from PamGene),0.9,Accept,Experimental Usage
,IBM SPSS Statistics,Analysis Software,27.01,,,,,,,PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,Statistical analyses were conducted using IBM SPSS Statistics (version 27.01),0.8,Accept,Experimental Usage
,PERADIGM,Analysis Software,,Not specified,,,,,,PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"Here, we introduce PERADIGM ( Phenotype Embedding similarity-based RAre DIsease Gene Mapping), a novel framework that leverages natural language processing techniques",0.95,Accept,Development
,PLINK,Analysis Software,,,,,,,,PMID:41411243 | PMID:32869517,10.1371/journal.pgen.1011976 | 10.1002/mgg3.1400,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping. | Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"we implemented stringent quality control (QC) measures on the whole-exome sequencing (WES) data using PLINK [ 51 ] | multidimensional scaling (MDS) analysis estimating pairwise identity by descent (IBD) for all pairs of founders using independent SNPs in PLINK (Purcell et al., 2007)",0.9,Accept,Experimental Usage
,Word2Vec,Package/Library,,,,,,,,PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,We employed the Word2Vec embedding model to obtain static embedding vectors for the phenotypes,0.9,Accept,Experimental Usage
,skyscan 1172,Analysis Software,,,,,,,,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,Bone samples were analyzed with low (6 µm voxel) or high (up to 1 µm voxel) resolution microCT from skyscan 1172,0.9,Accept,Experimental Usage
,Labview 7.0,Analysis Software,7.0,,,,,,,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Both the camera and the tensile tester were controlled by customized software (Labview 7.0, National Instruments)",0.85,Accept,Experimental Usage
,bam-readcount,Analysis Software,,,,,,,,PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,bam-readcount was then used to compute additional quality parameters,0.9,Accept,Experimental Usage
,regioneR,Package/Library,,R,,,,,,PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,Variants were filtered using the regioneR bioconductor package,0.9,Accept,Experimental Usage
,CLC Genomics Workbench v6,Analysis Software,v6,,,,,,,PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,CLC Genomics Workbench v6 (Qiagen) was used to analyze data from I2HCP V1,0.9,Accept,Experimental Usage
,Seurat V3.0,Package/Library,V3.0,R,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Data were analyzed by the Seurat V3.0 package in the R programming environment,0.9,Accept,Experimental Usage
,STAR 2.4.2.8,Analysis Software,2.4.2.8,,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The raw transcript counts were aligned to Refseq related to the build GRCh38-mm10 using STAR 2.4.2.8,0.9,Accept,Experimental Usage
,GSVA package,Package/Library,,R,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The ssgesa was calculated by the GSVA package with default settings,0.9,Accept,Experimental Usage
,GraphPad Prism version 5.01,Analysis Software,5.01,,,,,,,PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"AUCs were compared with two-way ANOVA followed by Bonferroni post-tests, using GraphPad Prism version 5.01",0.85,Accept,Experimental Usage
,STATA 11,Analysis Software,11,,,,,,,PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"distributions were first checked for normality by using the Shapiro–Wilk's test with STATA 11 (StataCorp, College Station, TX)",0.85,Accept,Experimental Usage
,Schrödinger software suite release 2017–1,Analysis Software,2017-1,,,,,,,PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,"Briefly, the Schrödinger software suite release 2017–1 was used for system setup.",0.85,Accept,Experimental Usage
,AMBER16,Analysis Software,16,,,,,,,PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Equilibration and production steps were performed using the AMBER16 MD engine,0.9,Accept,Experimental Usage
,VMD (version 1.9.3),Analysis Software,1.9.3,,,,,,,PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Descriptors were generated with in-house scripts using VMD (version 1.9.3) to calculate solvent accessible surface area,0.9,Accept,Experimental Usage
,gromacs (version 4.6),Analysis Software,4.6,,,,,,,PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,g_mindist tool of gromacs (version 4.6) to get residue–residue contacts,0.9,Accept,Experimental Usage
,MATLAB version 2019b,Analysis Software,2019b,MATLAB,,,,,,PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,The predictive power of the trained models was internally checked via 5-fold cross validation procedure available in MATLAB version 2019b,0.85,Accept,Experimental Usage
,PredictSNP2,Web Application,,,https://loschmidt.chemi.muni.cz/predictsnp/,,,,,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,The effects of mutations on protein functions were analyzed using the PredictSNP2 tool (https://loschmidt.chemi.muni.cz/predictsnp/),0.9,Accept,Experimental Usage
,iStable,Web Application,,,,,,,,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"The iStable-integrated server, accessible at predictor.nchu.edu.tw/iStable, features two machine learning-based tools",0.9,Accept,Experimental Usage
,Align GVGD,Web Application,,,http://agvgd.hci.utah.edu/agvgd_input.php,,,,,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,Align-GVGD (http://agvgd.hci.utah.edu/agvgd_input.php) is another tool that applies the Grantham difference,0.9,Accept,Experimental Usage
,SNPeffect 4.0,Analysis Software,4.0,,,,,,,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,These mutations were subjected to further phenotyping analysis using SNPeffect 4.0,0.85,Accept,Experimental Usage
,iMutant 2.0,Analysis Software,2.0,,,,,,,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,We selected the iMutant 2.0 and MUpro algorithms to predict the thermodynamic parameter changes,0.85,Accept,Experimental Usage
,Gel-Pro Analyzer 4.0 software,Analysis Software,4.0,,,,,,,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"Densitometry analysis was performed with Gel-Pro Analyzer 4.0 software (Media Cybernetics; Silver Spring, MD)",0.85,Accept,Experimental Usage
,R statistical package,Analysis Software,,R,http://cran.r-project.org/,,,,,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,All the analyses were implemented by the comprehensive statistical package R (http://cran.r-project.org/),0.8,Accept,Experimental Usage
,SPSS version 19.0,Analysis Software,19.0,,,,,,,PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"The statistical analyses were undertaken using a licensed version of SPSS (version 19.0, SPSS Inc, Chicago, IL, USA) compatible with Windows",0.8,Accept,Experimental Usage
,CHOPCHOP,Web Application,,,https://chopchop.cbu.uib.no/,,,,,PMID:33934112 | PMID:39415595,10.1038/s41419-021-03716-6 | 10.1242/dmm.050862,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,CHOPCHOP (https://chopchop.cbu.uib.no/) was used to identify the sgRNA sequence | gRNAs for zebrafish nf2a and nf2b (Table S1) were designed using CHOP-CHOP,0.9,Accept,Experimental Usage
,Ethovision 11,Analysis Software,11,,,,,,,PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,"Locomotor activity was analyzed using Ethovision 11 software (Noldus Information Technology, Wageningen, The Netherlands)",0.9,Accept,Experimental Usage
,Vevo 2100 micro-imaging system,Analysis Software,,,,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Sonographic measurement was performed using a Vevo 2100 micro-imaging system (VisualSonics, Amsterdam, Netherlands)",0.9,Accept,Experimental Usage
,Vevo software version 5.0.0,Analysis Software,5.0.0,,,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Three-dimensional images of the xenografts were generated and analyzed using the Vevo software version 5.0.0 to calculate their size in volume,0.9,Accept,Experimental Usage
,Chipster software,Analysis Software,,,http://chipster.csc.fi/,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Alignment and analysis was performed using a Galaxy server and open source Chipster software (http://chipster.csc.fi/),0.85,Accept,Experimental Usage
,R bioconductor,Package/Library,,R,http://www.bioconductor.org/,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,as well as R bioconductor (http://www.bioconductor.org/) tools for calculating similarity clusters on a Galaxy server,0.8,Accept,Experimental Usage
,ARACNe-AP algorithm,Analysis Software,,,,,,,,PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,the network was built using the ARACNe-AP algorithm. The ARACNe-AP algorithm reconstructs gene regulatory networks from large-scale gene expression data,0.9,Accept,Experimental Usage
,DESeq2 version 1.18.1,Package/Library,1.18.1,R,,,,,,PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,The differential expression and fold change calculations on the RNA-Seq datasets were performed using the R package DESeq2 version 1.18.1,0.9,Accept,Experimental Usage
,Dragen program,Analysis Software,,,,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were mapped to the genome and variants identified using the Dragen program with default settings,0.9,Accept,Experimental Usage
,GATK pipeline,Pipeline,,,,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The resulting VCF files were then sorted and updated to remove errors and analysed using the GATK pipeline,0.9,Accept,Experimental Usage
,HudsonAlpha RNA-seq data analysis pipeline,Pipeline,,,,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Post-processing of the sequencing reads from RNA-seq experiments for each sample was performed using HudsonAlpha's unique in-house RNA-seq data analysis pipeline,0.9,Accept,Experimental Usage
,TopHat v2.0,Analysis Software,v2.0,,,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Raw reads were mapped to the reference human genome hg19 using TopHat v2.0 with the -p 4 and -r210 arguments,0.85,Accept,Experimental Usage
,Cufflinks v0.9.3,Analysis Software,v0.9.3,,,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were quantified by both Cufflinks v0.9.3,0.85,Accept,Experimental Usage
,Cutaneous NF Github repository,Web Application,,,http://www.github.com/Sage-Bionetworks/dermalNF,,,,,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"All data is currently stored in the synapse web portal, and is accessible using code in the Cutaneous NF Github repository at http://www.github.com/Sage-Bionetworks/dermalNF",0.95,Accept,Development
,QuPath (v0.4.3),Analysis Software,v0.4.3,Java,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,QuPath (v0.4.3) was used to quantify the percentage of cells with positive or negative immunostaining,0.95,Accept,Experimental Usage
,R (version 4.3.1),Analysis Software,4.3.1,R,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,"All statistical analyses were performed in R (version 4.3.1) using the 'survival', 'survminer', and 'stats' packages",0.85,Accept,Experimental Usage
,R v3.6.3,Analysis Software,v3.6.3,R,,,,,,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"A Shapiro-Wilk test (base R v3.6.3, shapiro.test function) was used to test the normality",0.9,Accept,Experimental Usage
,BSDA v1.2.0,Package/Library,v1.2.0,R,,,,,,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"compared to estimate the P value of the real observations (real P value) (using BSDA v1.2.0, z.test function)",0.85,Accept,Experimental Usage
,gdata v2.18.0,Package/Library,v2.18.0,R,,,,,,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"resampled 10,000 times to produce 10,000 possible combinations of age-adjusted proportions (using gdata v2.18.0, resample function)",0.85,Accept,Experimental Usage
,ggplot2 v3.3.2,Package/Library,v3.3.2,R,,,,,,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,The distributions of bootstrapped P values were visualized using R (ggplot2 v3.3.2),0.85,Accept,Experimental Usage
,Affymetrix Mouse Gene 2.0 ST array,Analysis Software,,,,,,,,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,All the probe sets on Affymetrix Mouse Gene 2.0 ST array (Mogene-2_0-st-v1.na33.2.mm10),0.9,Accept,Experimental Usage
,WebGestalt webserver,Web Application,,,http://bioinfo.vanderbilt.edu/webgestalt/,,,,,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,Gene set enrichment analysis was performed using the WebGestalt webserver (http://bioinfo.vanderbilt.edu/webgestalt/),0.9,Accept,Experimental Usage
,MedCalc,Analysis Software,v16.8.4,,,,,,,PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software",0.85,Accept,Experimental Usage
,Stata 15,Analysis Software,15,,,,,,,PMID:37174087,10.3390/cancers15092621,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.,,"...All analyses were performed using Stata 15 (StataCorp, College Station, TX, USA)...",0.8,Accept,Experimental Usage
,ichorCNA,Analysis Software,v.0.2.0,,,,,,,PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,copy-number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0),0.9,Accept,Experimental Usage
,Python sklearn,Package/Library,v.1.3.2,Python,,,,,,PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,We then used the Python sklearn library (v.1.3.2) decomposition module incorporating up to 20 components,0.85,Accept,Experimental Usage
,10x Genomics Cell Ranger 7.0.1,Analysis Software,7.0.1,,,,,,,PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,BCL files were processed using 10x Genomics Cell Ranger 7.0.1,0.9,Accept,Experimental Usage
,Seurat V3 package,Package/Library,V3,R,,,,,,PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Each data set was analyzed individually from its raw count matrix using the Seurat V3 package [29],0.9,Accept,Experimental Usage
,SAS software Version 9.4,Analysis Software,9.4,,,,,,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"The data were analyzed using SAS software Version 9.4 (SAS Institute, Cary, NC, USA), with the significance level set at 0.05",0.85,Accept,Experimental Usage
,Analyze 12.0,Analysis Software,12.0,,,,,,,PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Using the multispectral neural network (MSNN) modeling tool available in Analyze 12.0 (AnalyzeDirect, Overland Park, KS)",0.9,Accept,Experimental Usage
,MIM Encore 6.9.3,Analysis Software,6.9.3,,,,,,,PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Measurements were made on a commercially available image analysis software (MIM Encore 6.9.3, MIM Software INC, Cleveland, OH)",0.9,Accept,Experimental Usage
,Genome Analysis Toolkit (GATK),Analysis Software,,,https://gatk.broadinstitute.org,,,,,PMID:41564118 | PMID:39669605,10.1371/journal.pone.0340183 | 10.1016/j.gimo.2024.101816,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,Variant calling of the germline samples was performed using The Genome Analysis Toolkit (https://gatk.broadinstitute.org) | SNVs/indel variants and SNPs were called using version 3.8 of the Genome Analysis Toolkit (GATK).,0.9,Accept,Experimental Usage
,nf-core sarek pipeline (v2.7.1),Pipeline,v2.7.1,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,WES and WGS data processing was performed with a modified version of the Nextflow nf-core 'sarek' data processing pipeline (v2.7.1),0.95,Accept,Experimental Usage
,DeepVariant,Analysis Software,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,The pipeline was modified to add DeepVariant as an additional variant-calling method,0.9,Accept,Experimental Usage
,nf-core rnaseq pipeline (v3.5),Pipeline,v3.5,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Transcriptomic data processing was performed using the nf-core 'rnaseq' data processing pipeline (v3.5),0.95,Accept,Experimental Usage
,XF24 Extracellular Flux Analyzer,Analysis Software,,,,,,,,PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"OCR was assessed in real-time with the XF24 Extracellular Flux Analyzer (Agilent, North Billerica, MA, USA)",0.9,Accept,Experimental Usage
,LC-MS/MS (Quattro Premier),Analysis Software,,,,,,,,PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Mass spectrometry analysis was carried out with an LC-MS/MS (Quattro Premier interfaced with an Acquity UPLC system, Waters)",0.9,Accept,Experimental Usage
,FACSCanto II flow cytometer,Analysis Software,,,,,,,,PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Samples were analyzed on a FACSCanto II flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA)",0.9,Accept,Experimental Usage
,FACSDiva software,Analysis Software,,,,,,,,PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,Data acquisition and analysis were performed using FACSDiva software,0.9,Accept,Experimental Usage
,Ventana-785-Raman spectrometer,Analysis Software,,,,,,,,PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"guiding the signals from the Raman probe to the spectrometer (Ventana-785-Raman, Ocean Optics, Rochester, New York, USA)",0.9,Accept,Experimental Usage
,SPSS software v. 21,Analysis Software,21,,,,,,,PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Analyses of neuropsychological and clinical data were performed using SPSS software v. 21 (IBM),0.8,Accept,Experimental Usage
,GAMESS software,Analysis Software,,,,,,,,PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,Quantum mechanics/molecular mechanics (QM/MM) computations...were performed using the General Atomic and Molecular Electronic Structure System (GAMESS software),0.9,Accept,Experimental Usage
,Mutiwfn 3.7,Analysis Software,3.7,,,,,,,PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Mutiwfn 3.7, VMD, and the GAMESS-optimized SEL-DDQ complex were used in the hirshfeld surface HS study",0.85,Accept,Experimental Usage
,DYNAMIC software,Analysis Software,V7.1.4,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"DYNAMIC software (V7.1.4) was used to obtain the normalized time autocorrelation function, polydispersity, and the absolute molecular mass",0.85,Accept,Experimental Usage
,Spectra Manager,Analysis Software,V1.17.00,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,using the Spectra Manager control (V1. 17.00) and application (V1.3.00) software package (JASCO),0.8,Accept,Experimental Usage
,Bindworks,Analysis Software,version 3.1.5,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The data were analyzed using the manufacturer provided software Bindworks (version 3.1.5, Calorimetry Sciences Corp. Lindon, UT)",0.85,Accept,Experimental Usage
,MantidPlot,Analysis Software,,,http://www.mantidproject.org/,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data reduction followed standard procedures that are implemented in MantidPlot (http://www.mantidproject.org/),0.85,Accept,Experimental Usage
,MATLAB (2019a),Analysis Software,2019a,MATLAB,,,,,,PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage
,SPM12 (version 7771),Analysis Software,7771,,,,,,,PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage
,EEGLAB (version 13.6.5b),Package/Library,13.6.5b,,,,,,,PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.9,Accept,Experimental Usage
,ATLAS.ti (Version 9),Analysis Software,Version 9,,,,,,,PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,"The coded transcripts were entered into ATLAS.ti (Version 9; Kansas City, MO)",0.95,Accept,Experimental Usage
,HaploReg v2,Web Application,v2,,,,,,,PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL putative genes were obtained from the HaploReg v2 web browser ( 36 ),0.85,Accept,Experimental Usage
,SPM12 v7771,Analysis Software,v7771,,,,,,,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom)",0.85,Accept,Experimental Usage
,MATLAB vR2020b,Analysis Software,vR2020b,MATLAB,,,,,,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom) through MATLAB vR2020b",0.8,Accept,Experimental Usage
,MRIcroGL,Analysis Software,,,https://www.nitrc.org/projects/mricrogl,,,,,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"For visualization purposes, all thresholded SPM maps were imported into MRIcroGL (https://www.nitrc.org/projects/mricrogl)",0.85,Accept,Experimental Usage
,Cell Ranger 5.0.1,Analysis Software,5.0.1,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,"Cell Ranger 5.0.1 (10x Genomics, https://www.10xgenomics.com/) was used to process the raw sequencing data.",0.9,Accept,Experimental Usage
,Seurat R package,Package/Library,v4.0.2,R,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The gene expression matrix from Cell Ranger was used as input to the Seurat R package (v4.0.2) for downstream analysis (53).,0.9,Accept,Experimental Usage
,Proteome Discoverer 2.4,Analysis Software,2.4,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,Data were acquired by the facility core and analyzed using Proteome Discoverer 2.4 (Thermo Fisher Scientific)...,0.9,Accept,Experimental Usage
,Salmon v1.8.0,Analysis Software,v1.8.0,,,,,,,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,RNA-Seq data from real and in silico mixed samples was aligned with Salmon v1.8.0,0.9,Accept,Experimental Usage
,nCounter Sprint Profiler,Analysis Software,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Gene expression analysis was conducted on the nCounter Sprint Profiler (NanoString Technologies, Inc.)",0.9,Accept,Experimental Usage
,nSolver Advanced Analysis Software version 4.0,Analysis Software,4.0,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Quality control, normalization, differential expression and pathway analysis were performed using nSolver Advanced Analysis Software (version 4.0)",0.9,Accept,Experimental Usage
,Omics Playground v2.7.18,Analysis Software,v2.7.18,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Raw count matrices with sample metadata deposited on GEO were reanalyzed using the Omics Playground v2.7.18 Platform,0.9,Accept,Experimental Usage
,UCSC Xena browser,Web Application,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Publicly available RNA sequencing data was also obtained from the TARGET TCGA GTEx database using the UCSC Xena browser (RRID:SCR_018938),0.9,Accept,Experimental Usage
,IDEP.92,Web Application,0.92,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Principal Component Analysis (PCA) was conducted in IDEP.92 using log2 transformed, normalized counts as input",0.9,Accept,Experimental Usage
,ComplexHeatmap R/Bioconductor package,Package/Library,,R,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,were generated using the ComplexHeatmap R/Bioconductor package (RRID:SCR_017270),0.9,Accept,Experimental Usage
,Scanpy,Package/Library,,Python,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Data preprocessing and visualization was performed using Scanpy (RRID:SCR_018139) in Python,0.9,Accept,Experimental Usage
,infercnvpy package,Package/Library,,,https://github.com/icbi-lab/infercnvpy,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,the infercnvpy package (https://github.com/icbi-lab/infercnvpy) was used to detect copy number variations,0.85,Accept,Experimental Usage
,HALO Image Analysis software version 2.0.5,Analysis Software,2.0.5,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Quantitative immunohistochemical analysis for BIRC5 and CENPF was conducted using the Cytonuclear IHC module of HALO Image Analysis software (version 2.0.5),0.9,Accept,Experimental Usage
,conumee,Package/Library,,R,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"To generate compound CNV plots using the DNA methylation data, we used the conumee package in Bioconductor",0.9,Accept,Experimental Usage
,Haplotype Caller,Analysis Software,,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files (VCFs)",0.9,Accept,Experimental Usage
,MuTect1,Analysis Software,v1.1.7,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files",0.95,Accept,Experimental Usage
,Variant Effect Predictor,Analysis Software,v92,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Raw VCF files were annotated with Variant Effect Predictor v92,0.95,Accept,Experimental Usage
,Sequenza,Analysis Software,v 2.1.2,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Additional analysis was applied to detect allele specific copy number profiles, loss of heterozygosity, and to estimate ploidy/cellularity using Sequenza for matched tumor/normal pairs",0.95,Accept,Experimental Usage
,MAVIS,Analysis Software,2.2.6,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,SVs were validated and visualized using MAVIS (version 2.2.6),0.95,Accept,Experimental Usage
,FusionCatcher,Analysis Software,,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,We used FusionCatcher to detect novel gene fusions,0.9,Accept,Experimental Usage
,STAR aligner,Analysis Software,2.4.2a,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"The reads were aligned to the human reference genome, hg38 using the star aligner (version 2.4.2a)",0.95,Accept,Experimental Usage
,AutoAnnotate,Plugin,1.2,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Highly related pathways were grouped into a theme and labeled by AutoAnnotate (version 1.2) in Cytoscape,0.9,Accept,Experimental Usage
,Enrichment Map,Plugin,3.1,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,GSEA results were visualized using the Enrichment Map app (Version 3.1) in Cytoscape,0.9,Accept,Experimental Usage
,CIBERSORT,Package/Library,,R,,,,,,PMID:33025139 | PMID:32098059 | PMID:37410426,10.1007/s00401-020-02230-x | 10.3390/genes11020226 | 10.1158/1078-0432.CCR-23-0749,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,"We used CIBERSORT Bioconductor package to perform deconvolution and estimate the abundances of cell types | we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31]. | DEGs were mapped to their human orthologs and were further analyzed using CIBERSORT (RRID: SCR_016955)",0.9,Accept,Experimental Usage
,GeneMapper software,Analysis Software,,,,,,,,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,electrophoresis data were analyzed using GeneMapper software (Life Technologies),0.9,Accept,Experimental Usage
,Agilent 1200 HPLC,Analysis Software,,,,,,,,PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage
,ABI 3200 MS/MS,Analysis Software,,,,,,,,PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage
,GraphPad Prism 5.0,Analysis Software,5.0,,,,,,,PMID:31527226 | PMID:24817309,10.1158/1535-7163.MCT-19-0123 | 10.1371/journal.pone.0097320,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.",,"GraphPad Prism 5.0 and 6.0 was used to perform all statistical analyses. Comparison of the means for nerve root volume, tumor number, KI-67 proliferation index | Statistical significance (p<0.05) was determined using the appropriate test as described in figure legends using GraphPad Prism 5.0 software",0.85,Accept,Experimental Usage
,FastQC (RRID:SCR_014583),Analysis Software,,,https://www.bioinformatics.babraham.ac.uk/projects/fastqc/,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,All resulting FASTQ files passed quality control by FastQC (RRID:SCR_014583; https://www.bioinformatics.babraham.ac.uk/projects/fastqc/),0.8,Accept,Experimental Usage
,TrimGalore (RRID:SCR_011847),Analysis Software,0.4.5,,https://www.bioinformatics.babraham.ac.uk/projects/trim_galore,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"RNA sequencing reads were 3′ trimmed for base quality 15 and adapter sequences using version 0.4.5 of TrimGalore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore, RRID:SCR_011847)",0.8,Accept,Experimental Usage
,STAR v2.6 (RRID:SCR_004463),Analysis Software,v2.6,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,and then aligned to human genome assembly hg19 with STAR v2.6 (RRID:SCR_004463) using default parameters,0.8,Accept,Experimental Usage
,HTSeq v0.9.1 (RRID:SCR_005514),Analysis Software,v0.9.1,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Read count tables were generated with HTSeq v0.9.1 (RRID:SCR_005514),0.8,Accept,Experimental Usage
,deepTools v3.1 (RRID:SCR_016366),Analysis Software,v3.1,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,These library size factors were also used with deepTools v3.1 (RRID:SCR_016366) to create normalized bigwigs using bamCoverage,0.8,Accept,Experimental Usage
,Homer v4.5 (RRID:SCR_010881),Analysis Software,v4.5,,http://homer.ucsd.edu,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Pathway enrichment (gene sets and GO) was performed on each cluster using Homer v4.5 (http://homer.ucsd.edu, RRID:SCR_010881)",0.8,Accept,Experimental Usage
,"featureCounts (v1.5.0-p1, RRID:SCR_012919)",Analysis Software,v1.5.0-p1,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"and used featureCounts (v1.5.0-p1, RRID:SCR_012919; ref. 79) to count RNA-seq fragments mapped to them",0.8,Accept,Experimental Usage
,"pheatmap (v.1.0.12, RRID:SCR_016418)",Package/Library,v.1.0.12,R,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"were subject to k-means clustering via pheatmap (v.1.0.12, RRID:SCR_016418), separately for the three classes of REs",0.8,Accept,Experimental Usage
,"Partek Genomics Suite (v 7.0, RRID:SCR_011860)",Analysis Software,v 7.0,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"PCA of methylation data at all tiles (regions) was generated in Partek Genomics Suite (v 7.0, RRID:SCR_011860)",0.8,Accept,Experimental Usage
,"FCS Express 7 Research Edition (De Novo Software, Inc.; RRID:SCR_016431)",Analysis Software,7 Research Edition,,,,,,,PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"All data were processed and analyzed with FCS Express 7 Research Edition (De Novo Software, Inc.; RRID:SCR_016431)",0.8,Accept,Experimental Usage
,Synapse,Database,,,https://doi.org/10.7303/syn4939906,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...Primary files [15] were accessed from Single Agent Screens through Synapse https://doi.org/10.7303/syn4939906...,0.8,Accept,Experimental Usage
,RENOVO-NF1,Analysis Software,,R,https://github.com/mazzalab-ieo/renovo,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Here, we optimized our random forest-based predictor RENOVO for NF1 variant interpretation. RENOVO was developed using an approach of 'database archaeology'",0.95,Accept,Development
,Mutation Taster,Web Application,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,The effects on genes and proteins of the variants identified were predicted based on the Mutation Taster (http://www.mutationtaster.org),0.9,Accept,Experimental Usage
,HGMD,Database,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"HGMD (Human Genome Mutation Database—Institute of Medical Genetics, Cardiff, Wales, UK; http://www.hgmd.cf.ac.uk/ac/index.php",0.9,Accept,Experimental Usage
,LOVD,Database,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,LOVD. (Leiden Open Variation Database; http://www.LOVD.nl.NF1),0.9,Accept,Experimental Usage
,PolyPhen-2,Web Application,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,Novel variants with amino acid changes were further examined for their disease causing. potential using PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/bgi.shtml),0.9,Accept,Experimental Usage
,ESE Finder,Web Application,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,and the ESE Finder (http://rulai.cshl.edu/cgibin/tools/ESE3/esefinder.cgi?process=home) tools,0.9,Accept,Experimental Usage
,GnomAD,Database,v.2.1.1,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,the GnomAD v.2.1.1 (https://gnomad.broadinstitute.org) and 1000 genomes databases were used,0.9,Accept,Experimental Usage
,1000 Genomes,Database,2015 aug,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"1000 genomes (https://www.internationalgenome.org, release 2015 aug) databases were used",0.9,Accept,Experimental Usage
,cutpointR,Package/Library,1.1.2,R,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"For threshold optimization, we used cutpointR version 1.1.2, maximizing the 'accuracy' metric",0.85,Accept,Experimental Usage
,ExplorDTI,Analysis Software,,,,,,,,PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Diffusion-weighted images were preprocessed using ExplorDTI (68),0.9,Accept,Experimental Usage
,Advanced Normalization Tools (ANTs),Analysis Software,,,,,,,,PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,"template, B0, for both controls and Plp-Nf1 fl/+ animals was created using Advanced Normalization Tools (ANTs) (70)",0.9,Accept,Experimental Usage
,NF Research Tools Database,Database,,,https://tools.nf.synapse.org/,,,,,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...the NF Research Tools Database, is an open-access database that enables the exploration and discovery of information about NF type 1-relevant animal models, cell lines, antibodies...",0.95,Accept,Development
,JSON-LD schema,Other,2.0.0,,https://github.com/nf-osi/nf-research-tools-schema,,,,,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We constructed a JSON-LD schema from the data model to make it machine-readable (version 2.0.0 at the time of writing...,0.85,Accept,Development
,Synapse collaborative science platform,Web Application,,,,,,,,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...but all database tables and a variety of 'joined' tables are available for anyone to access on the Synapse collaborative science platform...,0.9,Accept,Experimental Usage
,Salmon v1.4,Analysis Software,v1.4,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Raw FASTQ files were analyzed using the Salmon v1.4 alignment tool,0.9,Accept,Experimental Usage
,BWA-MEM2 v2.1,Analysis Software,v2.1,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Reads were aligned to hg38 using BWA-MEM2 v2.1,0.9,Accept,Experimental Usage
,GATK v4.1.9.0,Analysis Software,v4.1.9.0,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Base quality score recalibration (BQSR) was performed with GATK v4.1.9.0 BaseRecalibrator,0.9,Accept,Experimental Usage
,MCP-Counter,Analysis Software,,Unknown,,,,,,PMID:38744290 | PMID:32098059,10.1016/j.crmeth.2024.100772 | 10.3390/genes11020226,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"To assess the cell type of origin in the organoid models we used the tumor deconvolution algorithm MCP-Counter | we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31].",0.9,Accept,Experimental Usage
,BSBolt,Analysis Software,,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,raw fastq files obtained by RRBS were analyzed using BSBolt,0.9,Accept,Experimental Usage
,metilene v0.2-8,Analysis Software,v0.2-8,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Differentially methylated regions were detected using metilene v0.2-8,0.9,Accept,Experimental Usage
,DELLY v1.1.3,Analysis Software,v1.1.3,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Structural variants and copy number variation were called using DELLY v1.1.3,0.9,Accept,Experimental Usage
,InterVar,Analysis Software,update-2021-08-version,Unknown,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Germline variants are annotated using InterVar (update-2021-08-version),0.9,Accept,Experimental Usage
,rare disease workflows,Workflow,,Unknown,https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Our RNAseq analyses leverage the rare disease workflows at https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,0.85,Accept,Experimental Usage
,cNFOrganoidAnalysis,Analysis Software,,Unknown,https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,All computational tools used to generate Figures 4 and 5 for this manuscript are available on https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,0.9,Accept,Development
,Clustree,Package/Library,,R,https://github.com/lazappi/clustree,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,cluster number optimization was performed by comparing multiple cluster resolutions using Clustree,0.85,Accept,Experimental Usage
,Statistical Parametric Mapping toolbox (SPM8),Analysis Software,SPM8,,,,,,,PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"PET images were spatially processed using the Statistical Parametric Mapping toolbox (SPM8, Wellcome Trust Centre for Neuroimaging, 2008)",0.95,Accept,Experimental Usage
,Matlab 7.12.0,Analysis Software,7.12.0,MATLAB,,,,,,PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"implemented within Matlab 7.12.0 (MathWorks, Natick, MA, USA)",0.9,Accept,Experimental Usage
,kernlab R library,Package/Library,,R,,,,,,PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,we used the Gaussian Process regression (GPR) implementation available within kernlab R library,0.9,Accept,Experimental Usage
,PLIER,Package/Library,,R,,,,,,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.9,Accept,Experimental Usage
,vcf2maf,Command-line Tool,,,https://github.com/mskcc/vcf2maf,,,,,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Variant call format (VCF) files were processed using ""vcf2maf"" (https://github.com/mskcc/vcf2maf)",0.85,Accept,Experimental Usage
,MultiPLIER,Analysis Software,,,https://github.com/greenelab/multi-plier,,,,,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"We analyzed transcriptomic data from NF in the context of latent variables from MultiPLIER, a machine learning resource designed to aid in rare disease analyses [27].",0.9,Accept,Experimental Usage
,metaVIPER,Analysis Software,,,,,,,,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,We applied the metaVIPER algorithm [32] to infer protein regulatory activity based on the tissue gene expression profiles.,0.9,Accept,Experimental Usage
,NF Data Portal,Database,,,,,,,,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,All data analyzed in this article are stored on the NF Data Portal [24] (http://nfdataportal.org),0.9,Accept,Experimental Usage
,R 4.0.3,Analysis Software,4.0.3,R,,,,,,PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,Data standardization was performed using the R 4.0.3,0.9,Accept,Experimental Usage
,miRTarBase,Database,,,,,,,,PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"we retrieved miRNA information from the miRTarBase database, including, over 50,000 experimentally validated miRNA-target associations",0.9,Accept,Experimental Usage
,connectivity map (CMap),Database,,,,,,,,PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we uploaded our list of up- and down-regulated genes into the connectivity map (CMap) database,0.9,Accept,Experimental Usage
,SPSS V.23,Analysis Software,V.23,,,,,,,PMID:28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,,Statistical analyses were undertaken using SPSS V.23,0.8,Accept,Experimental Usage
,CLC-workbench,Analysis Software,,,,,,,,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"Variants were validated by Sanger sequencing and analyzed using CLC-workbench (Qiagen, Hilden, Germany)",0.9,Accept,Experimental Usage
,PredictProtein,Web Application,,,https://www.PredictProtein.org,,,,,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Analyses of in silico protein modifications by the exon skipping were performed using the web-server version of PredictProtein,0.95,Accept,Experimental Usage
,GraphPad Prism software v7,Analysis Software,v7,,,,,,,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Statistical analysis was carried out using GraphPad Prism software v7,0.9,Accept,Experimental Usage
,CRISPRscan,Web Application,,,https://www.crisprscan.org/,,,,,PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,CRISPRscan (https://www.crisprscan.org/) was used to identify gRNA target sequences in exon 1 of the tgfb3 gene,0.9,Accept,Experimental Usage
,"MATLAB (R2008a, MathWorks, Natick, MA, USA)",Analysis Software,R2008a,MATLAB,,,,,,PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"Stimuli were generated with MATLAB (R2008a, MathWorks, Natick, MA, USA) and presented with the stimulation software STIM 2",0.85,Accept,Experimental Usage
,"STIM 2 (Neuroscan, Charlotte, NC, USA)",Analysis Software,2,,,,,,,PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"presented with the stimulation software STIM 2 (Neuroscan, Charlotte, NC, USA) with a display resolution of 1,280 × 1,024 × 32",0.9,Accept,Experimental Usage
,Scan 4.5 (Neuroscan),Analysis Software,4.5,,,,,,,PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,Data analysis was performed with Scan 4.5 (Neuroscan). We started the analysis by correcting the eye blinking artifacts,0.9,Accept,Experimental Usage
,"IBM SPSS Statistics, version 19",Analysis Software,19,,,,,,,PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"All statistical analyses were performed with IBM SPSS Statistics, version 19, software (IBM Corporation, Armonk, NY, USA)",0.85,Accept,Experimental Usage
,MATLAB software,Analysis Software,R2019a,MATLAB,,,,,,PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,"Electronic image files were processed using MATLAB software (MathWorks Inc., R2019a, USA)",0.8,Accept,Experimental Usage
,WGCNA package v1.69,Package/Library,v1.69,R,,,,,,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,The conserved gene regulation networks and the correlation between drug responses and the gene network were determined using the WGCNA package v1.69,0.85,Accept,Experimental Usage
,Leiden Open Variation Database (LOVD),Database,,,www.lovd.nl,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,The publically accessible variant databases included were Leiden Open Variation Database (LOVD) ( www.lovd.nl ),0.85,Accept,Experimental Usage
,ClinVar NCBI,Database,,,www.ncbi.nlm.nih.gov/clinvar,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,ClinVar NCBI ( www.ncbi.nlm.nih.gov/clinvar ),0.85,Accept,Experimental Usage
,Human Gene Mutation Database (HGMD),Database,,,www.hgmd.cf.ac.uk/ac/all.php,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,the Human Gene Mutation Database (HGMD) ( www.hgmd.cf.ac.uk/ac/all.php ),0.85,Accept,Experimental Usage
,Clinical Interpretation of Variants in Cancer (CIViC),Database,,,https://civicdb.org/home,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Clinical Interpretation of Variants in Cancer (CIViC) ( https://civicdb.org/home ),0.85,Accept,Experimental Usage
,Mastermind Genomic Search Engine,Web Application,,,https://www.genomenon.com/mastermind,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Mastermind Genomic Search Engine ( https://www.genomenon.com/mastermind ),0.85,Accept,Experimental Usage
,Alamut Visual version 2.15,Analysis Software,2.15,,,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variants were imported into the clinical prediction software Alamut Visual version 2.15 (SOPHiA GENETICS),0.9,Accept,Experimental Usage
,gnomAD v2.1.1,Database,v2.1.1,,gnomad.broadinstitute.org,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variant frequencies and ExAC constraint metrics were obtained from gnomAD v2.1.1 ( gnomad.broadinstitute.org ),0.9,Accept,Experimental Usage
,UCSC LiftOver tool,Web Application,,,genome.ucsc.edu/cgi-bin/hgLiftOver,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,UCSC LiftOver tool was used for any genomic co‐ordinate conversions between genome builds GRCh37/hg19 and GRCh38/hg38,0.85,Accept,Experimental Usage
,alleleFrequencyApp,Web Application,,,cardiodb.org/allelefrequencyapp,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Maximum credible population allele frequency was determined using the alleleFrequencyApp ( cardiodb.org/allelefrequencyapp ),0.85,Accept,Experimental Usage
,CanVar-UK cancer predisposition gene variant database,Database,,,www.canvaruk.org,,,,,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,CanVar‐UK cancer predisposition gene variant database ( www.canvaruk.org ) was used in the search for further variant information,0.85,Accept,Experimental Usage
,Beta Imager 2000Z Digital Beta Imaging System,Analysis Software,,,,,,,,PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"Quantitation was performed using the Beta Imager 2000Z Digital Beta Imaging System (Biospace, France)",0.9,Accept,Experimental Usage
,Siemens Focus F220,Analysis Software,,,,,,,,PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,data acquired as 1h dynamic scans using the Siemens Focus F220 and Inveon scanners,0.9,Accept,Experimental Usage
,Illumina bcl2fastq v1.8.4 software,Analysis Software,v1.8.4,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were generated from Binary Cluster Files (.bcl) using the Illumina bcl2fastq v1.8.4 software with parameters set as per vendor's specifications,0.9,Accept,Experimental Usage
,Burrows-Wheeler Aligner v0.7.10,Analysis Software,v0.7.10,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were aligned to the human genome reference hg19 (GRCh37) using the Burrows-Wheeler Aligner v0.7.10 algorithm with default settings,0.9,Accept,Experimental Usage
,Picard Tools v1.119,Analysis Software,v1.119,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,BAM files (.bam) were generated using Picard Tools v1.119,0.9,Accept,Experimental Usage
,MDLVC v5.0,Analysis Software,v5.0,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,variant calling was performed using in-house variant caller algorithm (MDLVC v5.0),0.9,Accept,Experimental Usage
,HaplotypeCaller (Genome Analysis Tool Kit 3.3),Analysis Software,3.3,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,cross referenced with HaplotypeCaller (Genome Analysis Tool Kit 3.3) under discovery mode,0.9,Accept,Experimental Usage
,Integrated Genomics Viewer v2.3.4 (IGV),Analysis Software,v2.3.4,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"All variant calls were inspected using Integrated Genomics Viewer v2.3.4 (IGV; Broad Institute, MIT Harvard, Cambridge, MA)",0.9,Accept,Experimental Usage
,GraphPad Prism version 8.0,Analysis Software,8.0,,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA)",0.85,Accept,Experimental Usage
,R version 3.3.2,Analysis Software,3.3.2,R,,,,,,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA), SAS version 9.4 (Cary, NC), and R version 3.3.2",0.85,Accept,Experimental Usage
,melodic v3.15,Analysis Software,v3.15,,,,,,,PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,we ran group-based ICA using melodic v3.15,0.9,Accept,Experimental Usage
,fMRI Expert Analysis Tool (FEAT),Analysis Software,,,,,,,,PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,We used fMRI Expert Analysis Tool (FEAT) to model extracted time series,0.9,Accept,Experimental Usage
,Multiple Imputation by Chained Equations (MICE),Package/Library,,R,,,,,,PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,using a predictive mean matching for mixed types and the Multiple Imputation by Chained Equations (MICE) package in R,0.9,Accept,Experimental Usage
,CRISPResso2,Analysis Software,,,,,,,,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"At least 10,000 high-quality reads were analyzed for each sample using CRISPResso2 (Clement et al., 2019)",0.9,Accept,Experimental Usage
,Cellpose,Analysis Software,,Python,,,,,,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ",0.9,Accept,Experimental Usage
,Xenosplit,Analysis Software,,,,,,,,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"For PDX sequence data, Xenosplit was used to filter mouse-derived reads",0.9,Accept,Experimental Usage
,Variant Effect Predictor (VEP),Analysis Software,,,,,,,,PMID:37246765 | PMID:33591953,10.1093/neuonc/noad097 | 10.1172/jci.insight.146351,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Variant filtering and annotation were done using Variant Effect Predictor (VEP) | includes best-practices variant filtering and annotation with Variant Effect Predictor (VEP; version 95),0.9,Accept,Experimental Usage
,maftools v2.10.0,Package/Library,v2.10.0,R,,,,,,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Somatic variant plots were created with maftools v2.10.0,0.9,Accept,Experimental Usage
,CNVkit V2.0,Analysis Software,V2.0,,,,,,,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,CNVkit V2.0 was used to infer and visualize copy number,0.9,Accept,Experimental Usage
,DESeq2 package,Package/Library,,R,,,,,,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Gene counts and transcript counts were normalized by using the DESeq2 package,0.9,Accept,Experimental Usage
,GEOquery,Package/Library,,R,,,,,,PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.9,Accept,Experimental Usage
,Biobase,Package/Library,,R,,,,,,PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.9,Accept,Experimental Usage
,R statistical software version 3.5.1,Analysis Software,3.5.1,R,,,,,,PMID:32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,,All analyses were done with R statistical software version 3.5.1,0.85,Accept,Experimental Usage
,Seurat 3.1.0,Package/Library,3.1.0,R,,,,,,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics) and Seurat 3.1.0,0.95,Accept,Experimental Usage
,CellChatDB,Database,1.5.0,R,,,,,,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,CellChatDB (version 1.5.0) was used to infer ligand–receptor interactions between and within individual subpopulations,0.9,Accept,Experimental Usage
,Space Ranger,Analysis Software,v1.2.1,,,,,,,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"Sequencing data were processed with Space Ranger (10 × genomics, v1.2.1)",0.9,Accept,Experimental Usage
,Seurat v4.0.1,Package/Library,v4.0.1,R,,,,,,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,followed by analysis in R using the Seurat (v4.0.1) tool suite,0.95,Accept,Experimental Usage
,R Studio PKNCA package (version 0.9.3),Package/Library,0.9.3,R,,,,,,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,Selumetinib plasma concentration–time data were analyzed using noncompartmental methods implemented in R (version 3.6) R Studio PKNCA package (version 0.9.3),0.9,Accept,Experimental Usage
,STAR mapper (Version 2.4.1d),Analysis Software,2.4.1d,,,,,,,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,RNAseq reads were mapped with the STAR mapper (Version 2.4.1d),0.9,Accept,Experimental Usage
,Picard tools,Analysis Software,,,https://github.com/broadinstitute/picard,,,,,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Duplicate read pair detection was carried out with Picard tools,0.85,Accept,Experimental Usage
,QURNAs,Pipeline,,,https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/LY8ZQ4,,,,,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event,0.95,Accept,Development
,Alamut v2.15 (Interactive Biosoftware),Analysis Software,v2.15,,,,,,,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Alamut v2.15 (Interactive Biosoftware) was used to identify true splice-donor and acceptor sites,0.9,Accept,Experimental Usage
,Burrows-Wheeler Aligner (bwa-0.7.15),Command-line Tool,0.7.15,,,,,,,PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,FASTQ files were first aligned to the human reference genome (hg19) by the Burrows-Wheeler Aligner (bwa-0.7.15),0.85,Accept,Experimental Usage
,Sambamba (v0.6.6),Command-line Tool,v0.6.6,,https://github.com/biod/sambamba,,,,,PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,PCR duplications that cause bias in copy-number analysis were filtered out using Sambamba (v0.6.6),0.85,Accept,Experimental Usage
,CASAVA v1.82,Analysis Software,v1.82,,,,,,,PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,Raw image files were processed using CASAVA v1.82 for base calling and generating the raw sequencing data.,0.8,Accept,Experimental Usage
,SNP & Variation Suite v8.3.4,Analysis Software,v8.3.4,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Quality control for targeted gene sequencing data was done using SNP & Variation Suite v8.3.4 (http://goldenhelix.com/products/SNP_Variation/index.html),0.95,Accept,Experimental Usage
,EMMAX,Analysis Software,,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"tests of association between each SNP and log‐transformed CALM number, adjusted for age, sex, and body surface area, were performed with EMMAX (Kang et al., 2010)",0.9,Accept,Experimental Usage
,METAL,Analysis Software,,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Meta‐analyses between the CALM1 and CALM2 cohort studies were performed with METAL (Willer, Li, & Abecasis, 2010)",0.9,Accept,Experimental Usage
,ComPaSS-GWAS,Analysis Software,,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"The second approach for corroboration of SNP associations used ComPaSS‐GWAS (Sabourin et al., 2018), a method based on complementary pairs stability selection",0.9,Accept,Experimental Usage
,Haploview 4.2,Analysis Software,4.2,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Haploview 4.2 (Barrett, Fry, Maller, & Daly, 2005) was used to generate LD plots across the genome based on D' and r2 values",0.95,Accept,Experimental Usage
,GTEx,Database,V7,,,,,,,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"eQTL results for all CALM‐associated SNPs and collated genes based on 749 normal skin tissues were then extracted from GTEx (V7, dbGaP Accession phs000424.v7.p2)",0.85,Accept,Experimental Usage
,Adobe Photoshop CS2,Analysis Software,CS2,,,,,,,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,An attached Olympus DP72 camera and Adobe Photoshop CS2 were used to capture the images,0.85,Accept,Experimental Usage
,Peak Scanner software from Applied Biosystems,Analysis Software,,,,,,,,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,The UCSF Genome Core using Peak Scanner software from Applied Biosystems performed PCR fragment analyses,0.9,Accept,Experimental Usage
,SDS3.0,Analysis Software,3.0,,,,,,,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Allelic discrimination plots generated by SDS3.0, an Applied Biosystems program used to make genotyping calls",0.85,Accept,Experimental Usage
,COSMIC Database,Database,,,www.sanger.ac.uk/genetics/CGP/cosmic,,,,,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"The Catalogue of Somatic Mutations in Cancer Database (COSMIC, www.sanger.ac.uk/genetics/CGP/cosmic, Wellcome Trust Sanger Institute, United Kingdom) was used to search for references",0.9,Accept,Experimental Usage
,Prizm v.4 (GraphPad),Analysis Software,v.4,,,,,,,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,All analyses were performed using Prizm v.4 (GraphPad),0.85,Accept,Experimental Usage
,nf-core/rnaseq (v3.11.2),Pipeline,v3.11.2,Unknown,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,Raw fastq files were processed using nf-core/rnaseq (v3.11.2),0.9,Accept,Experimental Usage
,salmon (v1.10.1),Analysis Software,v1.10.1,Unknown,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,quantified using salmon: v1.10.1,0.9,Accept,Experimental Usage
,sva R package (v3.42.0),Package/Library,v3.42.0,R,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,ComBat from sva R package (v3.42.0) was used for batch correction,0.9,Accept,Experimental Usage
,immunedeconv (v2.1.0),Package/Library,v2.1.0,R,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The batch corrected data was then analyzed using the immunedeconv (v2.1.0) package,0.9,Accept,Experimental Usage
,ggplot2 (v3.4.4),Package/Library,v3.4.4,R,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage
,ggridges (v0.5.5),Package/Library,v0.5.5,R,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage
,HALO imaging analysis software,Analysis Software,,Unknown,,,,,,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,"analyzed with the HALO imaging analysis software (Indica Labs, Corrales, NM)",0.9,Accept,Experimental Usage
,FreeSurfer,Analysis Software,"5.3, 7.2.0",,,,,,,PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,the data were processed using Freesurfer (https://surfer.nmr.mgh.harvard.edu version 5.3)...processed using Freesurfer (version 7.2.0),0.9,Accept,Experimental Usage
,FACSDiva v6.1,Analysis Software,v6.1,,,,,,,PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data,0.85,Accept,Experimental Usage
,FlowJo software v10.0.8,Analysis Software,v10.0.8,,,,,,,PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data,0.85,Accept,Experimental Usage
,GraphPad Prism v8.3,Analysis Software,v8.3,,,,,,,PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,The IC50s for each of the cell lines were determined using GraphPad Prism v8.3 (nonlinear regression and dose–response curve fitting),0.85,Accept,Experimental Usage
,HALO image analysis software v3.2,Analysis Software,v3.2,,,,,,,PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,Tissues were scored for extent and intensity of staining using the HALO image analysis software v3.2,0.85,Accept,Experimental Usage
,ZEN imaging software v2.3,Analysis Software,v2.3,,,,,,,PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Image acquisition was performed using a Zeiss LSM 880 with Airyscan confocal microscope (Zeiss, Oberkochen, Germany) and analyses performed with ZEN imaging software v2.3",0.85,Accept,Experimental Usage
,CLC Genomics Workbench 22,Analysis Software,22,,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Resulting FASTQ files were analyzed with CLC Genomics Workbench 22 (QIAGEN, Hilden, Germany)",0.9,Accept,Experimental Usage
,CosinorPy Python package,Package/Library,,Python,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,numerical and graphical analysis was done using the CosinorPy Python package,0.9,Accept,Experimental Usage
,pCLAMP 9.2,Analysis Software,9.2,,,,,,,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.9,Accept,Experimental Usage
,Volocity 4.2,Analysis Software,4.2,,,,,,,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,The number of swellings per calyx was counted on 3D-rendered (Volocity 4.2; Improvision) images of calyces,0.9,Accept,Experimental Usage
,ImageJ 1.46,Analysis Software,1.46,,,,,,,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,images of calyx terminals were binary thresholded using the built-in thresholding function of ImageJ 1.46 (isodata algorithm),0.9,Accept,Experimental Usage
,Igor 6.22A,Analysis Software,6.22A,,,,,,,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics),0.85,Accept,Experimental Usage
,NeuroMatic,Package/Library,2.00,,,,,,,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics) NeuroMatic (version 2.00, kindly provided by Dr. J. Rothman)",0.85,Accept,Experimental Usage
,Disambiguate v1.0,Analysis Software,v1.0,,,,,,,PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"For PDX sequence data, Disambiguate v1.0 was used to filter out mouse-derived reads",0.9,Accept,Experimental Usage
,UPhyloplot2,Analysis Software,,,https://github.com/harbourlab/UPhyloplot2,,,,,PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,The Uphyloplot2 (https://github.com/harbourlab/UPhyloplot2) was used to visualize the clonality,0.9,Accept,Experimental Usage
,HISAT2 version 2.2.1,Analysis Software,2.2.1,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"To align the reads, we employed HISAT2 version 2.2.1 against the GRCh38 human genome",0.9,Accept,Experimental Usage
,StringTie version 2.2.1,Analysis Software,2.2.1,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Read counts were normalized by StringTie version 2.2.1,0.9,Accept,Experimental Usage
,DEGseq version 1.48.0,Package/Library,1.48.0,R,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Differential expression analysis was analyzed by DEGseq version 1.48.0,0.9,Accept,Experimental Usage
,ClusterProfiler version 4.2.2,Package/Library,4.2.2,R,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,the GSEA KEGG method with ClusterProfiler version 4.2.2 was applied,0.9,Accept,Experimental Usage
,STRING version 11.5,Web Application,11.5,,https://string-db.org/,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,protein–protein interaction analysis using STRING version 11.5,0.9,Accept,Experimental Usage
,FlowJo™ software v10.8,Analysis Software,10.8,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The data were analyzed by v10.8 of FlowJo™ software,0.9,Accept,Experimental Usage
,Seahorse Wave Pro software,Analysis Software,,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The analysis was performed with Seahorse Wave Pro software (Agilent Technologies, Santa Clara, CA, USA)",0.9,Accept,Experimental Usage
,GraphPad Prism version 9,Analysis Software,9,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The analysis was performed using GraphPad Prism version 9,0.9,Accept,Experimental Usage
,Agilent Tapestation 4200,Analysis Software,,,,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Fragmented gDNAs were tested for size distribution and concentration using an Agilent Tapestation 4200 and Qubit dsDNA High Sensitivity kit.,0.9,Accept,Experimental Usage
,Varsome Clinical Software v.12.3.2,Analysis Software,v.12.3.2,,,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Candidate somatic variants, consisting of point mutations, insertions, and deletions were sorted out with Varsome Clinical Software v.12.3.2 (Saphetor, Lausanne, Switzerland).",0.95,Accept,Experimental Usage
,Plotly v4.9.3,Package/Library,v4.9.3,R,https://plotly-r.com,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The VAF plot was generated using Plotly v4.9.3 in the R environment (available from https://plotly-r.com).,0.85,Accept,Experimental Usage
,CNVKit version 0.9.11,Analysis Software,0.9.11,,,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Finally, to determine the profiles of the alterations in the number of copies, the CNV calling was also performed using the CNVKit version 0.9.11.",0.9,Accept,Experimental Usage
,ggplot2 v3.5.1,Package/Library,v3.5.1,R,https://ggplot2.tidyverse.org,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The output was then visualized using ggplot2 v3.5.1 (https://ggplot2.tidyverse.org).,0.85,Accept,Experimental Usage
,GEPIA,Web Application,,,http://gepia.cancer-pku.cn/,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Kaplan–Meier survival curves were generated using GEPIA (http://gepia.cancer-pku.cn/) on the TCGA-SARC, TCGA-LUAD and TCGA-LUSC RNA-seq expression dataset.",0.9,Accept,Experimental Usage
,Cluster Profiler v.4.0,Package/Library,v.4.0,R,,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Gene Ontology (GO) and pathway enrichment analysis was performed using Cluster Profiler v.4.0, selecting statistically significant terms and pathways.",0.9,Accept,Experimental Usage
,UpSetR Version 1.4.0,Package/Library,1.4.0,R,,,,,,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Visualization of intersecting sets was performed with UpSetR Version 1.4.0 (R package).,0.85,Accept,Experimental Usage
,MATLAB® version R2007a,Analysis Software,R2007a,MATLAB,,,,,,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"statistical hypothesis testing were performed by the software package MATLAB®, version R2007a (The MathWorks, Inc., Natick, MA, USA)",0.8,Accept,Experimental Usage
,FlowJo v10,Analysis Software,v10,,,,,,,PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,"data analyzed using FlowJo v10 (Becton Dickinson, RRID: SCR_008520)",0.9,Accept,Experimental Usage
,ImageJ (v1.48),Analysis Software,v1.48,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,The volume of tumour spheroids was measured using ImageJ (v1.48) software,0.9,Accept,Experimental Usage
,HALO (Indica Labs),Analysis Software,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage
,Aperio Image Analysis (Leica Biosystems),Analysis Software,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage
,XF96 Extracellular Flux Analyzer (Agilent Technologies),Analysis Software,,,,,,,,PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,Oxygen consumption rate (OCR) was measured in schwannoma and normal Schwann cells 24 h post protein delivery using an XF96 Extracellular Flux Analyzer,0.9,Accept,Experimental Usage
